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ABSTRACT

Angelopoulos, Sophia Despina. M.S., Department of Chemistry, Wright State University,
2022. Gene Vectors with Fluorescence Tracking Capabilities.
This project focuses on the optimization of benzothiazole-based chromophores to
utilize them as fluorescent tags functionalized onto stimuli-responsive, or “smart,”
polymers as non-viral gene delivery vectors for gene therapy applications. Bluefluorescent emissive chromophores will allow tracking capabilities for the transfection
pathway of the vector to be monitored as it delivers the DNA payload within intercellular
space. The most appropriate chromophore must be covalently bound to a free amine
within the vector, which is accomplished through NAS chemistry from fluorophenylbenzothiazoles (F-BTZ-CBz) derivatives to amidated hyperbranched
poly(ethyleneimine)(HPEI-IBAm0.61). HPEI is considered to be a synthetic polycation,
which promotes tunable solubility through characteristics of lower critical solution
temperature (LCST), which can alter transfection efficiency. These features also allow
for the polymer to alter its morphology through dual-stimuli responses to pH and
temperature changes. UV-Vis and fluorescence data can verify the blue-emission
properties of both free chromophores and tag-functionalized polyplexes, which can also
be paired with green fluorescent protein payloads (GFP) to view efficacy and
cytotoxicity.
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I.

Introduction

Curing illness through gene therapy
Gene therapy involves therapeutic techniques that encompass gene manipulation
to improve the health conditions of a patient. Whether or not diseases are genetically
inherited or environmentally driven, such as muscular dystrophy, hemophilia, sickle cell
amenia, Parkinson’s, and/or Alzheimer’s, diseases can be treated through gene therapy
applications.1 In order for this to be accomplished, the corrective gene must be delivered
on a vehicle to survive the conditions within the body. This vehicle is more formally
known as a gene “vector” that aids the travel from entrance within the body, navigate
through a travel path, and up until the release within a cell. Considering the delicacy of
DNA components, the strand must survive harsh environments such as pH fluctuations,
temperature deviations, and immune responses before being implemented within a certain
cell’s nucleus. Without a suitable complex to protect the strand from threatening
conditions, the DNA components do not have a high survival rate before implication as a
naked strand without being protected through encapsulation. However, the application of
a vector can successfully deliver a gene without repercussions to the strand’s integrity.
In regard to application, vectors also have targeting capabilities towards specified
cells, such as liver, kidney, and/or any organ’s cells that consist of unique protein
markers on the endosomal layer. Gene therapy can treat a variety of ailments from
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numerous modes of administration such as chemotherapy drugs, synthetic proteins, and
siRNA/pDNA vaccinations.1
Endocytosis of Cells
There are several different modes for cell internalization within the general
classifications of active and passive transport, and one of which is endocytosis.
Endocytosis simply involves the process at which a cell engulfs a foreign substance
through extending its membrane to form a capsule to introduce the object within the
cytoplasm. A variety of cells will have the potential to engulf nanoparticles through
different mechanisms. As an example, macrophages, which are a type of white blood
cells that are heavily involved with the body’s immunity, internalize large molecules
through phagocytosis, or cell eating of macromolecules into vacuoles.2 Phagocytotic
methods are uncommon to ingest vector complexes because this is a more energetically
inefficient method of ingestion. There are non-phagocytic methods such as pinocytosis,
or cell drinking through internalizing molecules with their environment that can be
performed by practically all cells throughout the body.
There are two different methods of pinocytosis: fluid-phase and receptormediated pinocytosis. Fluid-phase pinocytosis is less common in gene delivery
mechanisms because they are generally non-specific means of internalization, which
indicates a lack of selectivity towards particular cells. Receptor-mediated pinocytosis
differs through stimulating receptors on the cellular membrane by ligand-functionalized
vectors. This promotes a binding affinity for the cell to encapsulate a foreign substance.
This is an optimal mechanism for gene delivery vectors because of the selectivity of
certain proteins in order to target cells for therapy treatment.2
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Once the complex is engulfed within the cell, there are new environments that are
endured that can induce different morphologies. The configuration of vectors can change
in response to fluctuation of temperature and pH. Core body temperature can range
anywhere between 36.5-38.5 °C and arterial blood pH within 7.35-7.45 but intracellular
pH can be as low as 5.3 The effectiveness of the complex to infiltrate within the
boundaries of the cell membranes through receptor-mediated pinocytosis, in this case, is
known as transfection efficiency. Figure 1 demonstrates the general mechanism of gene
delivery to dispense therapeutic genes within the nucleus of a cell.

Figure 1. General mechanism for gene incorporation within a cell through methods of endocytosis.

Gene Vectors
Gene delivery can be accomplished by two different classes of delivery vehicles,
known as viral and non-viral vectors. The main differentiating factor between viral and
non-viral vectors is that viral vectors do not require specific receptors to attack cells in
the body. This is a disadvantage because viral vectors have limited specificity compared
to non-viral vectors to which cell it is permitted to target because it is considered nonselective. However, it has a very effective method of infiltration into cells to implement
its DNA. On the other hand, non-viral vectors have the potential to target certain cells by
3

introducing substituents to attack specific receptors. Because of this concept, non-viral
vectors can target a variety of different cells based upon the substituent’s interaction in
certain bodily conditions.
Viral vectors have two well-known disadvantages: cytotoxicity and
immunogenicity.4 Cytotoxicity is considered to be correlated with apoptosis of cells
caused by chemotherapeutic treatments, such as gene therapy. Viral vectors also induce
immunogenicity, which is triggering bodily immune responses by a foreign invader.3
Viral vectors implement their DNA within strands of cellular DNA with a process known
as insertional mutagenesis. Insertional mutagenesis can be defined as ectopic
genetic/chromosomal integration that can cause cells to transform particular genes to
tumor cells—commonly known as oncogenes—leading to malignancies.4
Non-viral vectors present benefits of cost efficiency, reduced toxicity, decreased
pathogenic effects, and simplicity of production. The major advantage to non-viral gene
therapy is the increasing bio-safety factors.4 These types of vectors are a much safer route
opposed to viral vectors because of a diminished pathogenic risk. This relates to the
methods of implementing non-viral DNA into cells through the transfection process.
The downside to non-viral vectors is a lack of efficiency in the transfection
process. This is because they have a poor method of deploying their transgenes within an
infiltrated cell. Non-viral vectors encompass techniques that utilize cationic lipids (or
polyplexes) that are positive in charge, and this is accomplished through electrostatic
interactions.5 The backbones of DNA structures are negatively charged, which contribute
to the electrostatic interactions between the vectors and genes resulting in what are called
polyplexes. The issue with the use of polyplexes for gene delivery is that their lifetime is
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brief because they are typically attacked by phagocytes, which are a part of the
mononuclear phagocyte system.6,7
Effective non-viral vectors have common features to bind efficiently to DNA and
maximize in transfection. These characteristics include strong electrostatic interactions
between DNA and charged polymeric vector, tunable hydrophobic/hydrophilic balance,
amine-based cationic backbone, and long-chain micellar configuration.8 There are several
examples of non-viral vectors utilized for purposes of gene therapy, such as poly(lysine)
(PLL), poly(aminoamine) (PAMAM), poly(dimethylaminoethylmethacrylate)
(PDMAEMA), and poly(ethyleneimine) (PEI), which are represented in Figure 2 below.

Figure 2. Structures of common polymeric non-viral gene vectors.

Mechanisms of Ingestion
Phagocytes have the purpose of ingesting foreign particles, invaders, or dying
cells in order to protect their biological systems. Receptors on the surface of phagocytes
determine what type of foreign invader they target.7 Through the manipulation of
hydrophilic polymers on the surface of a non-viral vector, a greater transfection
efficiency can be achieved.5 As the phagocyte engulfs the foreign body under certain
conditions via vesicle formation, the vesicle detaches from the cell wall and fuses with
the endosome.9 The DNA that penetrates into the cell is either delivered to a lysosome or
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evacuated through the cytoplasm. The breakdown of newly ingested material alters the
pH within the endosome to become more acidic from 6.0 to 4.8.8
DNA, DNA combined with liposomes/pegylated nanocomposites, or small RNA
can infiltrate a cell by means of electroporation, which is the process of inducing pores
through a surface through the use of pulses of electricity.10,11 The DNA is not integrated
within the cell’s strand of DNA, but rather “curls up” within the boundaries of the cell
membrane.3 This prevents the risk of insertional mutagenesis, which is promoted by viral
vectors.
Changing functional groups on lipids or polyplexes impacts the toxicity, charge
density, and solubility.3 Cationic lipids or polyplexes have the capability of becoming
toxic to cells within the body. Cationic lipids are comprised of 3 basic structures: a
positively charged head group, a hydrophobic chain, and a connecting link between the
polar and nonpolar end.12 Single-tailed, aliphatic chains existing as a cationic lipid have
been proven to have the highest toxicity rates and lowest transfection efficiency. Toxicity
and structure are proven to be highly correlated with one another. Cationic lipids have the
potential to cause local toxicity (at an injection site) and/or system toxicity (referred
distribution to other organs).12
In addition, considering that the DNA exists as a naked strand, it must have a
means to protect itself from its external environment. Even through strands can be
manually generated to be as long as desired, having smaller sizes to encapsulate DNA is
preferable to gain the most effective infiltration rates within a cell through the process of
electroporation.13 Figure 3 refers to the polyplex formation between a therapeutic gene
and gene vector that can implement DNA to a host cell through a transfection process.

6

Figure 3. Mechanism of vector and gene forming a polyplex, so that the vector can infiltrate the cell and release its
payload within the nucleus.

Stimuli Responsiveness
The harsh and fluctuating conditions that a polyplex will endure cannot be
avoided in the pursuit of transfecting a gene within a host cell. Adapting and responding
to these various conditions to alter the morphology of the vehicle to either dispense or
clamp on to the DNA payload is necessary to complete this endocytic pathway. Stimuliresponsiveness is a property that allows for this change in morphology.14 This is
especially useful for the biomedical applications because of the pH and temperature
alterations that are inevitably being encountered with a system in vivo.
Factors of temperature
Solubility can be best correlated with the Flory-Huggins equation that is
temperature dependent in this case. The Flory-Huggins parameter (denoted with the
Greek letter χ) is an empirical term that represents the polymer interaction level in a
particular solvent.15 Within dilute solutions, these relations are best described through
7

analyzing the modified Flory-Huggins equation shown in Equation 1, where ΔHm
represents the enthalpy of mixing, kB is the Boltzmann’s constant, T is the temperature of
the system, N1 is the number of molecules that contribute to component one, and V2
demonstrates the volume of component two.
𝜒=

Δ𝐻!
𝑘" 𝑇𝑁# 𝑉$

[1]

The thermodynamic characteristics can be best described when combining the
terms with the definition of the Gibb’s energy of mixing demonstrated in Equation 2,
where the terms have been established in the Equation 1.16
Δ𝐺! = 𝑘𝑇(𝑁# ln(𝑣# ) + 𝑁$ ln(𝑣$ ) + 𝜒# 𝑁# 𝑣$ )

[2]

Analyzing the expression, the first two terms depict an entropic variable, while the last
term is purely enthalpic. With the assumption of free volume being constant within the
system stated by incompressibility, the second virial expression incorporating the FloryHuggins parameter can propose a new equation that can depict where the parameter is
found at its most optimal temperature. After expanding Equation 2 to the partial molar
Gibb’s energy of mixing expression and integrating osmotic pressure, Equation 3
determines the Flory θ-temperature, to which χ is equivalent to 0.5.16
𝑣̅$ $ 1
𝐴$ =
2 − 𝜒# 7
𝑁% 𝑉# 2
This expression includes terms of v2, which is the specific volume of the polymer,
NA is Avogadro’s number, and A2 represents the second virial coefficient. The rationale
behind the most optimal temperature ensuring A2 to be zero is best described through the
properties of the solubility factors when the value of zero is approached. At this point,
chains are mixed with minimal recognition of the opposing solvent/solute moieties.
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[3]

The Flory-Huggins parameter is often associated with favorable entropy and
unfavorable enthalpy characteristics between polymer-solvent interactions at lower
temperatures.16 However, at low enough temperatures, the entropic characteristics
become dominated by enthalpic characteristics. From this, there is an apparent
diminished configurational entropy factor, which is defined as entropy related to the
position of moieties on a polymer chain rather than the velocity of particles.16 This
indicates that the configurational entropy is dependent on the length of the substituent
chains added to the main polymer chain. At particularly low temperatures, this
relationship of overruled entropy—specifically configurational entropy—by enthalpic
factors are derived from hydrophobic characteristics of the polymer with the solvent.17
The gauche conformation of a polymer is typically preferable and can be
demonstrated as such in ambient temperatures. In addition, it is associated with dipole
moments that assists in its solubility in polar solvents.18 The increase in temperature will
decrease electrostatic interactions which makes the gauche conformation not as favorable
at higher temperatures. This is the case because at higher temperatures, the polymer
endures a greater amount of steric hindrance between its own matrix of configurations.
The gauche conformation elicits a stronger dipole moment within the polymer. Therefore,
phase separation occurs at higher temperatures where there is a notable decrease in dipole
moment, thus making entropic conditions more favorable as a result.18 This also
correlates with polarity of water; when a polymer experiences more of these dipole
moments at lower temperatures, a monomer and water can be miscible because of the
factors of strong attractive forces of polarity. This verifies why the polymer is soluble at a
lower temperatures.
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Factors of pH
As stated previously, arterial blood typically ranges between a pH of 7.35-7.45,
which is maintained by buffer systems composed of bicarbonate, phosphate, and plasma
protein systems.19 Arterial blood requires a weak acid and its conjugate base to generate a
buffer system, however intracellular blood utilizes a different system that causes a
variation of pH. The mechanism regulating pH is the exchange of protons traveling
within the cell and exiting the cell, which avoids the use of a buffer.19 This directly relates
to the endocytic properties of a cell that is attracted to the positive charges integrated on
the polyplexes.
HPEI is considered a buffer because of the large number of amines present within
the backbone. This draws protons within the cell, thereby generating an acidic
environment for the DNA-polymer complex.3 An acidic environment induces the neutral
amines to become protonated and effectively decreases the pH of the intracellular fluid.
At this point, the slight drop in pH only tampers with the configuration of the polyplex
enough to cause protein folding to occur within the vacuole. This directly affects the
operation of the nucleus to be compromised, which inhibits degradation of the newly
introduced DNA delivered by the polyplexes.
Stimuli Responsiveness: Real-World Examples
Other useful applications can tangentially relate to biomedical applications that
also harness properties of dual-stimuli responsiveness. Another useful application that
can potentially utilize pH sensitivity is sensor applications. Typically, conjugated
polymers are required to be present because of their innate properties of fluorescence,
conductivity, emission/absorption, etc. to visually react to environmental changes. The
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key to conjugated polymers is their ability to recognize materials of interest through
optical signals.20 A significant aspect of optical amplification polymers is that at low
concentration it is able to demonstrate these characteristics even at lower molecular
weights because signal is transferred to the conjugated polymeric chain.
A common conjugated sensor that has gained much interest for its synthetic
compatibility and relative availability are polymers known as poly(diacetylenes)
(PDA’s). PDA is a stable vesicle once suspended in solution and will fluoresce blue in
certain conditions and red in response to other stimuli. PDA is paired with a pHresponsive phospholipid known as 1,2-dimyristoyl-sn-glycero-3-phosphocholine
(DMPC) that will protonate and deprotonate at certain pH conditions at the amine site.
This complex acts as the energy acceptor to whatever energy donor is substituted to
promote tunable fluorescence. From this feature, there is a potential to detect microbials
that influence pH fluctuations for the ligand to bind to receptors strictly based off color
changes in fluorescence emissions.20 Figure 4 represents the structures for this example
of pH-responsive functionalized polymers.

Figure 4. pH-responsive polymers that make the acceptor moiety to a fluorescent system.20

In addition to pH responsiveness, temperature change can act as a stimulus to
induce morphology or physical changes to a polymeric complex. A factor known as
solubility minimum involves water playing a major contribution to protein unfolding that
11

occurs with the decrease or increase of temperature.21 In order to stabilize the
polymer/DNA payload complex within acidic levels and temperature fluctuation in the
body, there must be a configuration transformation of the polymer/DNA payload. A wellknown functionalized temperature-responsive system known as poly(Nisopropylacrylamide) (PNIPAM) is a key example that undergoes phase transitions at
fluctuation temperatures.
Functionalizing PINIPAM through hydrophobic/hydrophilic monomer additions
can alter the miscibility to water solutions. Phase separation is a physical property that
can be monitored through conditions of varying concentrations of the functionalized
PNIPAM. Higher temperatures involve more of a phase separation between the media
and occurs with a decrease in dipole moment. The decrease in dipole moments is
associated to an increase of PNIPAM concentration, which promotes less miscibility the
more that is incorporated in the system.21 This leads to a lower temperature solubility for
more PNIPAM within a water solution to prevent phase separation. The main indicator
of temperature dependence is the manipulation of a solubility characteristic called “lower
critical solution temperature”. Figure 5 represents the structure of PNIPAM used within
this temperature-dependent study.21

Figure 5. Temperature responsive polymer with tunable hydrophobic/hydrophilic characteristics to alter miscibility in
water
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Lower Critical Solution Temperature (LCST)
Although polymers are soluble at ambient temperatures, they decrease in
solubility when correlated to increasing temperatures because of their properties of lower
critical solution temperatures (LCST).18 This is especially true in regard to the length of
the side chains attached to the polymer chain; the LCST decreases in response to longer
chains of substituents. Hydrophobicity plays a major role in solubility in solvents. In
general, polymers have hydrophobic characteristics which tend to decrease LCST.
LCST Relating to Temperature and pH
The rationale behind the concept of LCST is explained through thermodynamics;
the major components of solubility, such as entropy and enthalpy, are strongly dictated
by the temperature and pH of a sample. It can be assumed that spontaneity of Gibb’s
energy is a major component in the polymer’s LCST. Utilizing the definition of Gibb’s
energy, negative energy values are considered to be spontaneous. Thus, a decrease in
temperature will generate an overall favorable reaction due to consuming enthalpic
characteristics. Polymers with a strong interaction with water correlate with the entropic
term but becomes have an underwhelming contribution from the enthalpic term. In order
to stay dissolved, more energy must be inputted into the system. More of this energy
indicates a higher temperature required for dissolution, therefore the minimum
temperature required for dissolution increases. As this temperature increases, the polymer
collapses to the configuration of a globule, and then to a DNA strand. However, the
temperature effects vary depending on the amine groups added which can be protonated
in lower pH environments. The percentages of alkyl groups and amide groups
synthesized onto polymers alters the LCST depending on the hydrophobic/hydrophilic
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ratio. Hydrophobicity causes a decrease in LCST, which correlated with the arise in
percentage in amide groups.
pH can determine if the polymer contains protonated or deprotonated groups
which indicates an acid or base substituent. Under a lower pH environment, a basic
polymer would be more likely to protonate and develop a more positive charge, thus
being more ionic. Being more ionic will induce a stronger attraction to water and
increases LCST. With respect to a constant temperature, the pH environment can alter the
interactions of a polymer and DNA strand. The polymer must have an LCST that varies
with pH, otherwise the polymer-body interaction will not be as efficient. Along with this,
decreasing the pH not only causes the LCST to increase but the polymer will begin to
expand to release its DNA payload.3, 22 Figure 6 demonstrates various pH and temperature
morphology changes of a polyplex that demonstrates dual-stimuli responsiveness.

Figure 6. Conditions that trigger dual-stimuli responsiveness of pH and temperature fluctuations that lead to clamping
and dissociation of the vector to a DNA payload.3, 22

Polyplex Formation
In order to maintain an effective DNA-polyplex interaction, stabilization during
the transfection process is required. There are many different types of vectors that can be
used as vehicles for DNA payloads such as nanocarriers, dendrimers, liposomes, and
micelles.1 There is a commonality with these vectors, which is the binding to the DNA
14

backbone through electrostatic charges. Cationic vectors have an advantage of
compensating for this in higher concentrations and molecular weights, which, in turn,
leads to a greater abundance of cytotoxic transfected cells.23 In transfection studies, the
greatest attraction is towards micellar vectors because of their small diameters, strong
adsorption to DNA with stability, feasibility to manipulate molecular weight, and stimuli
responsiveness properties.23, 24
Formation of micelles is optimal for a multitude of reasons when considering the
polyplex’s necessity to respond to various stimuli. In terms of temperature dependency,
attaching DNA strands to nonpolar entities of the polymeric backbone can shield potent
environmental conditions that could potentially disassemble the polymeric strand.23, 24 To
accomplish this, the formation of micelles can be implemented, which translates to a nonpolar interior and polar exterior in spherical configuration. Incorporating micelles allows
for hosts to become the site for unfolding polymers in ionic or nonionic surfactant.21
There are disadvantages to other vector modes such as larger vehicles like
dendrimers and liposomes. Higher molecular weight polymers are inherently more
intractable and higher cost to process. These barriers enhance the appeal of polymeric
micelle formation as a delivery method for DNA payloads. Self-assembly of amphiphilic
cationic polymers is an apparent characteristic of several commercial polymer bases, such
as poly(ethylenimine).23, 24 With the appropriate hydrophobic/hydrophilic balance on a
polymeric backbone, this not only grants advanced degrees of structural definition, but
also avoids cytotoxicity of cells that can occur within gene replication processes.
Furthermore, polymeric backbones can also contain specific protein tags that correspond
to targeted cells or respond to selective environmental stimuli.
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Mechanisms demonstrated in in vitro studies reveal that the driving force for
cationic binding to DNA strands is through electrostatic interactions. Specifically, the
cationic surface attracts via hydrophilic interactions attracts DNA and has the ability to
transfect a variety of cell types by taking advantage of thermal and kinetical boundaries.
Higher transfection rates have been associated with complexes that have a higher N/P
ratio, meaning the cationic polymer charge (N) is greater than the negatively-charge
nucleic acid phosphate sites (P). Considering this ratio, the overall net-charge is
presumed to be positive not including the unbound, excess of cationic polymers. This
excess can densely pack in proximity to the cationic backbone, generating an even greater
cationic density, which further develops the binding affinity to DNA. Increased binding
affinity of the complex only strengthens the stability of vector-DNA transfer under
physiological conditions.23, 24
There are not only conformational factors that contribute to the transfection
efficiency; delivery performance is also dependent on nuclear entry, endosomal exiting,
cytotoxicity, and/or payload loading/release efficiency.23, 24 It is critical to maintain the
integrity of the complex to avoid pre-mature dissociation and release of the DNA
payload. Micellar aggregation plays the role of a counterion that induces a strong DNA
attachment, and thereby increases stability in the system.23,24 This alludes to the critical
factors of charge and size of the polyplexes influencing the stability of the complex.
When a polyplex reaches the stage of nuclear trafficking to release the payload, there
must be a pathway for the vector to be excreted from the system. This degradation
process has the potential to be monitored through methods of fluorescence emission
spectroscopy. It is critical to have a baseline understanding as to the classifications of
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emission, which directly relate to efficiency and allowable/forbidden mechanisms within
a fluorescent tagging complex.
Relaxation Pathways
There are a variety of relaxation pathways available to electronically-excited
states of molecules. These are depicted in Figure 7. Fluorescence and phosphorescence
are radiative relaxation paths, which are accompanied by photon emission. Fluorescence
is a spin-allowed transition between electronic states of the same spin multiplicity, for
example singlet-to-singlet or triplet-to-triplet transitions. Phosphorescence is a spinforbidden transition between states of different spin multiplicities, such as singlet-totriplet or triplet-to-singlet transitions. Owing to the allowed nature of fluorescence, the
radiative rate coefficients often are large, and the upper states often exhibit
correspondingly short lifetimes. Conversely, the lifetimes of upper states involved in
phosphorescence transitions are notably longer, owing to the smaller radiative rate
coefficients of these spin-forbidden transitions.25
Nonradiative relaxation pathways may involve collisions, or they may be
intramolecular and collision-free. Internal conversion is an intramolecular energy
transfer pathway between isoenergetic levels of an upper and lower electronic state
having the same spin multiplicity, for example, from vibrational levels of an S1 state to
high vibrational levels of S0. Intersystem crossing is an intramolecular energy transfer
pathway between isoenergetic levels of upper and lower electronic states of different spin
multiplicities, for example, a transition from vibrational levels of S1 to high vibrational
levels of T1. Multiple collisions between molecules can promote vibrational relaxation
from higher vibrational levels within an electronic state to lower levels. Excitation
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methods, whether optical or electronic, may play a role in the relative importance of the
various relaxation paths.25
Fluorescence
Fluorescence is classified as the movement of excitons through the transitional
excited electronic singlet state to ground electronic singlet state (S1-S0) levels. This is
derived from a S0-S1 absorption vibronic transition of electrons that will undergo
vibrational relaxation within the excited manifold to the lowest quantum number within
the same state. To prompt this, there must be an excitation source, such as electronic or
photochemical, to promote electron collision up to an excited state, typically through
vibrational frequencies. As electrons undergo the S1-S0 transition, energy is emitted in the
form of light that can be quantified into vibrational energy wavelengths. These photons
can transition to various quanta contained within the ground state, which gives rise to
different energy emissions. Because of this inherent phenomenon, the data collected
reveals information regarding the ground state of the molecule, where absorption studies
would reveal data for the excited states.26
Fluorescence can be attained by relative intensities of emission corresponding to
specific wavelengths, which is strictly dictated by the electronic population of excited
states undergoing the S1-S0 transition. Since there is a distinguishable difference between
photons within excited states and electrons within the ground, it is possible to calculate a
fluorescence quantum efficiency. This is simply the ratio between the number of emitted
photons to the number of excited electrons. Radiative lifetime mainly determined by
allowable and/or forbidden transitions of electrons and if they achieve thermal
equilibrium.26
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Phosphorescence
Phosphorescence mechanisms are analogous to that of fluorescence, but with the
stipulation that the excited electronic triplet state (T1) must be occupied to transition back
to the ground S0. In theory, the T1 could potentially be directly populated through
electrons from the S0 state. However, the absorption coefficient of S0-T1 is extremely low,
so it does not propose a feasible route of excited triplet state population.26 A more
plausible pathway derives from the excitation of S0-S1, but depending on the thermal
stability, the gap between the singlet and triplet manifolds, and/or the electron
configuration of the molecule, a phenomenon known as intersystem crossing (ISC) will
transfer the excitons to populate the triplet state. The electron population will undergo
collisional relaxation within the triplet state and emit from T1-S0. Theoretically, this is a
“spin forbidden transition” along with its low thermal stability but can be achieved
through process known as “spin orbit coupling”.26
Spin orbit coupling
Spin orbit coupling is an unusual phenomenon that is a widely accepted
explanation for unfavorable pathways. This property derives back to concepts of all
electrons within a population contain electron spin angular momentum that can
individually be calculated. During a transitional phase from one state to another, the spin
energy must be conserved considering factors of both spin and space of the transition.27
As stated in Becker, “Spin-orbit coupling effectively mixes some singlet character into
triplet states and some triplet character into singlet states this destroying their pure
character and orthogonal nature.”27 This infers that the two states are dependent of one
and will enhance the transition probability.
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The reasoning lies within the Hamiltonian summation; along with the inherent
Hamiltonian and electron repulsiveness quantities, spin-orbit interactions arise as a
realistic correction to incorporate the velocity of electrons when approaching the nucleus.
This can be influenced by the nuclear attraction to electrons within the cloud along with
the atomic radius of the molecule. The more electrons incorporated within a
configuration will increase the range of shielding effects between the nucleus, which
means that there is a direct correlation with electrostatic potential and an indirect
correlation with the radius of the molecule.27 This indicates that heavier atoms of higher
atomic number will enhance in spin-orbit coupling characteristics because the velocity of
electrons allows for a more highly penetrable nuclear core.27 With a dependence on larger
effective nuclear charge (Z) and radius (r), this promotes a higher probability of S1-T1
transitions.
An increased character of spin orbit coupling enhances the forbidden nature of the
transition. Due to the lack of a forbidden nature, much of the energy is transmitted in the
form of heat through non-radiative collisional relaxation. Vibrational relaxation transmits
heats within the same state, but no heat is expended from the isoenergetic transition from
S1-T1. To quantify this, the phosphorescence quantum efficiency is calculated similarly to
that of fluorescence considering that the photons must mediate through the S1 state. This
calculation remains as the ratio of the number of photons emitted from the T1-S0
transition and the number of electrons excited from the S0-S1 transition. The radiative
lifetime within phosphorescence differs in aspects of degeneracy and forbidden
characteristics of the T1-S0 transition.27
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Perturbations of singlet-triplet transitions
A major hinderance of both fluorescence and phosphorescence analyses is the
interference of molecular oxygen. The ground state of molecular oxygen is a triplet state,
which can promote quenching in various molecules’ singlet and triplet states. Oxygen
quenching is much more prevalent in samples within solution due to oxygen solubility
within the solvent. Fortunately, this is a reversible process that can be purged of oxygen
and will eliminate quenching entirely.28 This phenomenon has roughly equal occupance
within the triplet and singlet states, but ultimately effects phosphorescent emission more
readily. This is the case because oxygen interferes through collisional interactions, which
effect electrons that remain in a long lifetime because of the increase of collisional
interactions within triplet states. With respect to this, phosphorescence is hindered
inherently compared to fluorescence, which causes more dramatized intensity
diminishment. Molecular oxygen is also considered to be paramagnetic, which is
theorized to enhance spin-orbit coupling and increase the rate of S1-T1 transitions.28
Not only does molecular oxygen perturb the electronic pathway through spin orbit
coupling, but the presence of heavy atoms has also experimentally expressed increased
characteristics of S1-T1 transitions. It is proposed that there is a mixture between excited
states where “crossing” occurs that will promote forbidden transitions through electronic
collisions.29 This coincides with the “heavy atom effect” in that a more electronically
dense system will provoke forbidden transitions such as S1-T1.27, 29
The main principle that drives halogenated atoms to mimic effects of the “heavy
atom effect” are derived from its electron configuration. Within their ground-state
configuration, halogenated atoms contain a p block that is more than half filled orbital
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and consist of an unpaired electron. There is a strong dependency of spin orbit coupling
with nuclear mass dependency, which is best represented through comparing radiative
rates of halogenated species. Emission from X* to X (2P1/2 to 2P3/2) is forbidden by the
Laporte rule.25
The strength of spin orbit coupling increases with nuclear mass, as illustrated by
energy separation ΔE* to E increases in the series from fluorine (404 cm-1) to iodine
(7603 cm-1). The radiative rate of emission also increases in series from fluorine to iodine
while the corresponding X* lifetime decreases. The forbidden nature of the X* to X
emission is “relaxed” in series from fluorine to iodine by the heavy atom effect, to which
kradiative increases with mass and emission lifetime decreases. The most significant feature
of the ground state for spin orbit coupling still promotes a forbidden transition.25
Thermally Active Delayed Fluorescence (TADF)
A major hinderance with inherent mechanisms of fluorescence and
phosphorescence is the efficiency associated to the retention of photons from the excited
states. This retention, also known as the carrier collection efficiency, is tabulated through
the current applied compared to the photons emitted. This is dictated on the energy lost to
heat or simply not converting electrons to their photo-excited states. Depending on
methods of excitation, population ratios of singlet and triplet states can vary dramatically
to which electrical excitation will populate T1 and S1 states in a 3:1 ratio.30, 31 This is
primarily driven by factors such as intersystem crossing when considering spin
multiplicities.30 Photoexcitation will only grant population to the allowable transitions,
such as S0-S1, and will greatly differ the occupation ratio of singlet to triplet manifolds.
Intersystem crossing is a common occurrence with heavy or halogenated atoms as
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discussed previously, which will truly reduce the internal quantum efficiency of
fluorescence with the migration of photons from S1-T1.30, 31
However, there are competitive features to the singlet transitions compared to the
triplet transitions. The S1-S0 emission pathway is allowable, therefore kinetically
favorable, which induces a larger radiative rate coefficient. When the radiative rate is
high, the transition is much more rapid and decreases the migration probability to a
forbidden transition. The solution is to either prevent the pathway to this forbidden state
or to stimulate a reversable process back to the allowable transition. This process is
known as reverse intersystem crossing (RISC) and is achievable through a small energy
gap between singlet and triplet manifolds.30, 31 A main contributor to this energy gap
derives from the HOMO/LUMO gap, which is tunable depending on the structure of the
molecule. These mechanisms of fluorescence, phosphorescence, and TADF are illustrated
through Figure 7, which depict the phenomenon of intersystem and reverse intersystem
crossing.

Figure 7. Emission pathways of fluorescence, phosphorescence, and TADF through ideal energy gap separations
between the singlet (S1) and triplet (T1) manifolds.
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Fluorescent Tagging
A major obstacle of gene vector therapy is the monitoring the fate of the vector
once the vector releases the gene payload within the targeted cell. This could be degraded
within lysosomes within intracellular space, excreted through the liver pathways, or
various other modes of degradation processes. This is crucial even if the vector is
considered biodegradable because this helps quantify the threshold concentration that can
be withstood within the body, whether or not this is in lysosomes, kidneys, or other
vessels to degrade foreign compounds. It is possible to observe the vector’s pathway of
excretion by tagging vectors with fluorescent chromophores onto available substitution
sites.
Green fluorescent proteins (GFP’s)
Similar experiments have been implemented through green fluorescent protein
(GFP) indicators, which promoted fluorescent properties within the gene being delivered
to the nucleus. Methods of electroporation, which is implementing an electric field that
promotes permeation of cell membranes, and lipofection, which utilizes cationic lipids as
vectors to penetrate cell membranes, to the polyplex were applied to perform
fluorescence microscopy experimentation.32 This polyplex consisted of a phMGFP
plasmid vector and hMGFP synthetic gene, and the results indicated information on
transfection within the membrane. The results also revealed that the transfection
effectiveness was conditional to voltage applied during electroporation, time allowed for
the transfection period, and concentrations of phMGFP to hMGFP systems. GFP
fluorescence appeared in several locations within the membranes of cells, which
demonstrated that charged vectors contributed to a satisfactory transfection within cells.32
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Gene vectors with red fluorescent probes
Fluorescent vectors have also been explored to observe the pre- and posttransfection processes within the cell membrane monitor the pathway before and after the
payload is dropped off within the nucleus. Lower intensity red chromophore tags have
been studied with the objectives to enhance the targeting to specified cells, maximize
cellular uptake, and localize within the nucleus to release the payload properly.33 This
was executed utilizing micellar vector methods by conjugating perylene diamine (PDIC10C8) to poly(ethylenimine-g-poly(lactide-co-glycolide)-g-polyethylenimine (PLGAPEI) to form the multifunctional polymer and micelle unit (MP) and grafting this onto a
gene peptide sequence.33 Figure 8 represents the structures utilized to synthesize the
multifunctional polymer micelles with a conjugated unit and a tunable amine-based
polymer.

Figure 8. Multifunctional polymer and micelle vector unit (MP) utilized in red chromophore transfection studies.

Fluorescence stability could then be monitored through a phenomenon known as
“photobleaching”, which is the photochemical conversion from phosphorescence that is
represented by a fluorophore emitting as a non-fluorescent species, such as heat.
Photobleaching is in direct relation to the type of donor and the average time in the
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excited state and is indirectly related to the rate of electrons emitting to the ground state
and the fluorescence intensity.33
Photobleaching was observed through fluorescence spectroscopy by observing the
intensity over longitudinal studies at a specified wavelength of PGLA-PEI with a generic
CY5 fluorescent tag, MP micelles, and MP with grafted gene peptide sequence. The
results demonstrated a highly stable micellar complex with respect to the minimized
intensity drop over a 4-hour period, which indicated marginal photobleaching
characteristics.33 There was even less of an intensity drop within the MP micelles and MP
with grafted gene peptide sequence, which emphasizes that there is even more of a
stabilized complex formed when paired with the PDI-C10C8 conjugated species. In terms
of molecular transports through cellular membranes, bioimaging techniques indicated
successful nuclear trafficking that directly correlated with the micellar diameter.
Regardless of active or passive transport, internalization decreases with increasing
micellar size, which is a critical feature when optimizing transfection processes of nonviral vectors.33
Previous Work
Previous research revolving this subject matter has been performed by Skidmore
in 2010 with dual-stimuli responsive poly(ethylenimine) derivatives operating as gene
therapy vectors. Skidmore was the primary catalyst to the project and hypothesized that
PEI does not contain an LCST if it is not functionalized as its amidated formation. Very
minimal research had been executed at the time with manipulating amine-based polymers
to be suitable for biological studies that were reactive to pH and temperature changes.
The modifications made ultimately should lead to a lower LCST, which will enhance cell
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uptake and transfection efficiency. The main objectives were to create a method
development of synthesizing the vector, implement LCST studies, and employ in vitro
transfection studies including cytotoxicity studies. Modification routes of both
butoxylation and amidations were pursued, to which LCST had the ability to be
controlled and observed through UV-Vis turbidity studies.22
Abraham reflected off some of Skidmore’s final conclusions of the 54% amidated
HPEI vector expressing the most promising LCST results. Abraham’s goal was to
improve the transfection efficiency while attempting to minimize cytotoxicity by
functionalizing HPEI. A major obstacle was to understand if a sudden release promoted
by a rapid change in solubility transfect more effectively than a gradual released
promoted by a gradual change in solubility. It was also proposed that longer functional
groups will be less cytotoxic to cells because the cationic backbone will be less
prominent to the cell membrane, which could potentially cause degradation of the cell.
The following in Scheme 1 is a general schematic of functionalizing amidated HPEI with
longer functional groups to diminish cytotoxicity effects.3

Scheme 1. Mary Abraham’s proposed general synthetic route for alkylating HPEI-IBAm.3

With the optimizing vector synthesis route and minimized cytotoxic systems with
high transfection efficiencies established, the next focus was to attach a chromophore
moiety to either the primary or secondary amines. Bresler focused on the synthesis of a
27

blue TADF emitter with a diphenyl sulfone acceptor and carbazole donor group. This
chromophore could be attached to the HPEI backbone ~2% incorperation and tested
through fluorescence studies along with transfection with green fluorescent proteins to
monitor the fate of the vector before and after release of the DNA payload. Fluorescence
demonstrated a 400-450 nm blue light emission in water, and transfections results were
ongoing with the chromophore attached HPEI. Preliminary results indicated that the
transfection did not show signs of cytotoxicity.34
Current Work
One of the primary objectives of this research is to optimize a route to synthesize
a benzothiazole-based chromophore system that includes optimal reaction conditions,
workup, purification, and characterization methods. The synthesis consists of processing
various fluoro-benzothiazole acceptors and a carbazole donor, which will induce a blue
light emission when functionalized together. Characterization such as GC/MS, 1H, 13C
and 19F NMR spectroscopy are implied and can hint at the effects of donor-acceptor
interactions of a variety of chromophore derivatives. From here, UV-Vis and
fluorescence spectroscopy emission spectra can be obtained to observe HOMO/LUMO
gaps between the acceptor and donor moieties. This alludes to the quantum efficiency of
the chromophore, along with the most energetically favorable derivatives that should be
utilized to attach to the HPEI-IBAm amines.
Since PEI is cheap, easy to functionalize, and contains tunable amidation to
induce LCST properties, this is the poly(amine) vector of choice to attach the most
optimal chromophore, in terms of reactivity and efficiency. These unreacted amines on
vector that can be utilized to attach a blue-fluorescent tag to follow the vector in its
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transfection path. Experimentally, substitution does not take place at all available amines,
so blue-fluorescent tags can be inserted on the available amines through the same
experimental processes. Visually, this can be seen through UV-Vis or fluorescence
spectroscopy to confirm the attachment of HPEI and chromophore.
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II.

Experimental Methods

Materials
The following chemicals were purchased from Sigma Aldrich supplier:
Hyperbranched poly(ethylenimine) (HPEI) Lupasol ® WF (BASF, Mn=10,000 g/mol),
carbazole, calcium hydride, dimethyl sulfoxide (DMSO), chloroform-d3 (CDCl3),
hydrochloric acid (36.5%), potassium carbonate (K2CO3), GR ACS Acetone (99.5%), 2aminothiophenol, iso-butyryl chloride (98%), anhydrous tetrahydrofuran (THF, 99.9%),
tetrahydrofuran (without BHT inhibitor), acetonitrile (MeCN), sulfuric acid (H2SO4, 30%
free SO3), deuterium oxide-d2 (D2O), copper iodide (CuI (I)), N-N-dimethylglycine
(DMG), and iodomethane. The following chemicals and products were purchased from
Fisher Scientific supplier: Hexanes (98.5-99%), toluene (99.5%), ethyl acetate (99.5%),
red PTFE/white silicone septum for GC/MS, poly(phosphoric acid) (84%), Filter paper
(Whatman grade 2), chloroform (CHCl3), 4-fluorobenzoic acid, 2-fluorobenzoic acid,
dichloromethane (DCM), and potassium hydroxide (KOH).
The following chemicals were purchased from Oakwood Chemicals supplier:
Hexanes (98.5-99%), sodium bicarbonate (NaHCO3), ethyl acetate (99.5%), Lawesson’s
reagent (C14H14O2P2S4), sodium hydroxide (NaOH), N-iodosuccinimide, and 3fluorobenzoic acid. Other materials like ethanol 190 proof through Decon Labs and
Morton ® ionized salt from a local Meijer were purchased. Special preparations of
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materials such as distillation of iso-butyryl chloride under nitrogen, distilling DMSO over
calcium hydride under nitrogen, and storing/drying K2CO3 in a 150 °C oven was
employed. In addition, all high quality (HQ) water utilized was used ultra-purified via a
3-step purification process. All HQ water is processed through Wright State’s reverse
osmosis system with ion-exchange membrane through Dayton Water Company and a 5filter Labconco Water Pro Plus system.
Instrumentation
1

H, 13C, 19F Nuclear Magnetic Resonance (NMR) Bruker AVANCE at 300/400

MHz, respectively, where samples were dissolved in CDCl3 or D2O ~20-30 mg/0.6 mL.
A Hewlett-Packward (HP) 6890 Series GC coupled with an HP 5973 Mass Selective
Detector/Quadrupole was utilized to perform GC/MS analysis. Sample preparation
consisted of dissolving ~5 mg of sample in 1-1.5 mL of GR ACS Acetone (99.5%),
filtered through glass wool, and sealed sample with red PTFE/white silicone septum in
cap. UV-Vis on an Agilent Cary 60 UV-Vis Spectrometer along with an Agilent
Technologies Cary Eclipse Fluorescence Spectrometer were provided by Dr. Ioana Pavel
to obtain spectroscopy data. Melting points were obtained on a research grade melting
point apparatus by Electrothermal ® that does not need calibration. Rotary evaporation
was performed on a Yamato RE500 in a BM200 heated water bath and an Isotemp
ethylene glycol/water coolant system. The precision balance used was a Mettler Toledo
XS104 for weighing reagents and products. A Savant Speed-Vac (SC110) with attached
Refrigerated Vapor Trap (RVT4104) and Vacuum Pump (VP100) was utilized for
removing excess water from HPEI materials.
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Synthetic Methods
1.1 Synthesis of HPEI-IBAm.60 (7)
To an oven-dried 100 mL RBF equipped with a water condenser, nitrogen inlet,
and stir bar, were added HPEI (2.71 g, 46.4 mmol modifiable amines), triethyl amine
(55.1 mL, 0.395 mmol) and 411 mL of anhydrous THF. The resulting mixture was cooled
to 0 °C, in an ice bath, at which point iso-butyryl chloride (2.92 mL, 27.8 mmol) was
added dropwise to the system with vigorous stirring. The mixture was then left in the bath
to warm to room temperature overnight, followed by heating at 50 °C for 30 minutes. The
THF was removed via rotary evaporation and the remaining residue was dissolved in DI
water and subjected to aqueous dialysis for 48 hours (water replaced on the 24th hour).
After dialysis, the water was evaporated using a speed-vacuum with isolated glassy
orange-yellow solid. Yield: 3.65 g (77%). 1H NMR indicated 61% amidation of the
available amines. 1H-NMR (300 MHz, D2O): δ 1.06 (s, 6H), 2.45-3.47 (m, 10H) ppm.
13

C-NMR (75 MHz, D2O): δ 18.7-19.6, 23.0, 29.9, 35.0, 36.8 ppm.
2.1 Synthesis of 2-(3-fluorophenyl)-benzothiazole, 3-F-BTZ (2b)
The following material had previously been synthesized by Garrett Reinhard with

isolated blue chunky solid. Yield: 2.7316 g (56%).GC/MS (m/z): 229.0 amu; m.p. 86-89
°C. 1H-NMR (300 MHz, CDCl3): δ 7.18 (ddt, 3JH-H, 3JF-H = 8.3 Hz; 4JH-H = 2.5 Hz; 4JH-H =
1.0 Hz, 1H), 7.37-7.41 (dt, 3JH-H = 7.0 Hz; 4JH-H =1.1 Hz, 1H), 7.42-7.47 (ddd, 3JF-H = 8.3
Hz; 4JH-H = 3.3 Hz; 4JH-H = 1.9 Hz, 1H), 7.48-7.53 (dt, 3JH-H = 7.1 Hz; 4JH-H =1.2 Hz, 1H),
7.81-7.83 (ddd, 3JH-H = 6.1 Hz; 4JH-H = 3.3 Hz; 4JH-H = 1.0 Hz, 1H), 7.84-7.86 (dt, 3JH-H =
3.6 Hz; 4JF-H = 2.6 Hz, 1H), 7.90 (dd, 3JH-H = 8.0 Hz; 4JH-H = 1.7 Hz; 5JH-H = 0.6 Hz, 1H),
8.09 (dd, 3JH-H = 8.1 Hz; 4JH-H = 1.7 Hz; 5JH-H = 0.8 Hz, 1H) ppm. 13C-NMR (100 MHz,
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CDCl3): δ 114.4 (d, 2JC-F = 23.3 Hz), 117.9 (d, 2JC-F = 21.1 Hz), 121.8, 123.4 (d, 4JC-F =
2.9 Hz), 123.6, 125.6, 126.6, 130.7 (d, 3JC-F = 8.1 Hz), 135.2, 135.8 (d, 3JC-F = 8.1 Hz),
154.1, 163.1 (d, 1JC-F = 246.7 Hz), 166.5 (d, 4JC-F = 2.9 Hz) ppm. 19F-NMR (376.5 MHz,
CDCl3): δ -112.0 (s) ppm.
2.2.1 Synthesis of 2-(3-fluorophenyl)-6-iodo-benzothiazole, 3-F-BTZ-I (3b)
In an oven-dried 10 mL RBF, equipped with a nitrogen inlet, and stir bar, were
placed 2-(3-fluorophenyl)-benzothiazole (0.505 g, 2.21 mmol) and 1.5 mL of H2SO4. A
solution of N-iodosuccinimide (0.597 g, 2.65 mmol) in 2.0 mL of H2SO4 was added
dropwise to the 3-F-BTZ stirring solution over 24 hours. The resulting mixture was
stirred at room temperature for 24 hours at which point GC/MS analysis of an aliquot
precipitated from water indicated ~84% conversion. An additional 0.5 equivalents of
NIS solution (0.249 g, 1.11 mmol) were added, and the reaction was stirred for another
24 h. After 24 hours, GC/MS analysis of an aliquot precipitated in water indicated ~86%
conversion to monosubstituted product but 13% disubstituted product. The reaction
mixture was then added dropwise to 700 mL of stirred water, and the resulting precipitate
was isolated via vacuum filtration. The brown dried solid was dissolved in
dichloromethane (~13 mL) and transferred to a 125 mL separatory funnel. The organic
layer was washed with an equal volume of 5% NaHCO3 solution forming an emulsion.
Salt and more NaHCO3 solution were added in attempt to break up the emulsion layer.
The organic and residual emulsion layers were then washed with an equal volume of DI
water. The organic layer was dried over MgSO4, filtered, and the dichloromethane was
removed in vacuo using a rotary evaporator. The remaining solids were dissolved in
chloroform (~15 mL), placed in a 125 mL separatory funnel, and washed with an equal
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volume of 10% sodium bisulfite, three times with DI water, and once with brine solution.
The organic layer was dried over MgSO4, filtered, and the chloroform was removed using
a rotary evaporator. The remaining solids were recrystallized from EtOH/H2O and
triturated in MeCN/H2O with isolated light brown solid 90% purity. Yield: 280 mg (36
%). GC/MS (m/z): 355.0 amu; m.p. 144-146 °C. 1H-NMR (400 MHz, CDCl3): δ 7.21
(ddt, 3JH-H, 3JF-H = 9.1 Hz; 4JH-H = 8.3 Hz, 4JH-H = 2.2 Hz, 1H), 7.47 (ddd, 3JF-H = 9.4 Hz;
4

JH-H = 8.2 Hz, 4JH-H = 6.2 Hz, 1H), 7.77-7.84 (m, 4H), 8.25 (ds, 4JH-H = 1.9 Hz, 1H) ppm.

13

C-NMR (100 MHz, CDCl3): δ 90.1, 114.6 (d, 2JC-F = 23.8 Hz), 118.4 (d, 2JC-F = 21.1

Hz), 123.5 (d, 4JC-F = 2.7 Hz), 125.1, 130.4, 130.9 (d, 3JC-F = 8.2 Hz), 135.3 (d, 3JC-F = 7.5
Hz), 135.9, 137.3, 153.5, 163.2 (d, 1JC-F = 246.3 Hz), 167.1 (d, 4JC-F = 3.0 Hz), ppm. 19FNMR (376.5 MHz, CDCl3): δ -111.5 (s) ppm.
2.3.1 Synthesis of 2-(3-fluorophenyl)-6-(carbazol-9-yl)-benzothiazole, 3-F-BTZCBz (4b)
In an oven-dried 10 mL RBF, equipped with a nitrogen inlet, and stir bar, were
placed 3-fluorophenyl-iodo-benzothiazole (0.1349 g, 0.3798 mmol), CuI (0.0079 g,
0.0414 mmol), N,N-dimethylglycine (0.0083 g, 0.0415 mmol), K2CO3 (0.1578 g, 1.1418
mmol), and ~5 mL of DMSO. Following this, carbazole (0.1901 g, 1.1372 mmol) was
added to the stirring solution and heated to 90 °C over 24 hours. After 24 hours, GC/MS
analysis of an aliquot of the mixture indicated ~94% conversion. The reaction mixture
was then added dropwise to 200 mL of stirred water with salt, and the resulting
precipitate was isolated via vacuum filtration. The brown dried solid was dissolved in
chloroform (~50 mL) and transferred to a 125 mL separatory funnel. The organic layer
was washed with 2x60 mL DI water and 60 mL of brine. The organic layer was dried
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over MgSO4, filtered, and the chloroform was removed in vacuo using a rotary
evaporator. The remaining solids were recrystallized from ethanol/H2O and triturated in
acetonitrile with isolated light brown solid ~100%. Yield: 201.5 mg (38%). GC/MS
(m/z): 394.1 amu, m.p. 143-146 °C. 1H-NMR (300 MHz, CDCl3): δ 7.21-7.25 (ddt, 3JH-H ,
3

JF-H = 8.4 Hz; 4JH-H = 2.6 Hz; 4JH-H = 1.2 Hz, 1H), 7.29-7.35 (dt, 3JH-H = 9.9 Hz; 4JH-H =

3.3 Hz, 2H), 7.43-7.45 (m, 3JH-H = 4.0 Hz; 4JH-H = 2.3 Hz, 4H), 7.48-7.55 (ddd, 3JF-H =
10.8 Hz; 4JH-H = 4.2 Hz; 4JH-H = 2.4 Hz, 1H), 7.72 (dd, 3JH-H = 8.7 Hz; 4JH-H = 2.1 Hz, 1H),
7.86-7.91 (m, 3JH-H = 7.7 Hz; 4JH-H = 1.4 Hz, 2H), 8.12 (ds, 4JH-H = 2.2 Hz; 5JH-H = 0.6 Hz,
1H), 8.17 (dd, 3JH-H = 7.7 Hz; 4JH-H = 1.1 Hz, 2H), 8.28 (dd, 3JH-H = 8.7 Hz; 5JH-H = 0.4
Hz, 1H) ppm. 13C-NMR (100 MHz, CDCl3): δ 109.8, 114.5 (d, 2JC-F = 24.2 Hz), 118.3 (d,
2

JC-F = 21.0 Hz), 120.3, 120.4, 120.6, 123.5 (d, 4JC-F = 3.0 Hz), 123.7, 124.7, 126.2,

126.3, 130.9 (d, 3JC-F = 8.1 Hz), 135.4, 135.6 (d, 3JC-F = 8.0 Hz), 136.5, 141.2, 153.2,
163.2 (d, 1JH-H = 246.9 Hz), 167.6 (d, 4JC-F = 2.9 Hz) ppm. 19F-NMR (376.5 MHz,
CDCl3): δ -111.7 (s) ppm.
3.1 Synthesis of 2-(3-hydroxyphenyl)-6-(carbazol-9-yl)-benzothiazole, 3-OHBTZ-CBz (5a)
In an oven-dried 10 mL RBF, equipped with a nitrogen inlet, and stir bar, were
placed 2-(3-fluorophenyl)-6-carbazole-1,3-benzothiazole (0.0473 g, 0.1199 mmol) and
~0.5 mL of DMSO (0.24M). Following this, a 1:1 KOH/H2O mixture (0.0125 g, 0.025
mL) was added to the stirring solution and heated to 150 °C over 24 hours. After 24
hours, GC/MS analysis of an aliquot quenched with iodomethane indicated no conversion
to the methoxy product with significant amounts of 3-F-BTZ-CBZ remaining (67%). The
reaction mixture was heated to 165 °C to observe any change in conversion. After 96
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hours from the start of the reaction, GC/MS analysis of an aliquot methylated with
iodomethane confirmed that there was still no formation of methylated product.
4.1 Synthesis of 2-(2-fluorophenyl)-benzothiazole, 2-F-BTZ (2a)
In an oven-dried 250 mL RBF, equipped with a nitrogen inlet, water condenser,
and stir bar, were placed 2-fluorobenzoic acid (1.21 g, 8.63 mmol) and poly(phosphoric
acid) (~20 g). The mixture was heated and stirred at 90 °C until the benzoic acid was fully
dissolved. Following this, 2-aminothiophenol (0.92 mL, 8.6 mmol) was added to the
stirred solution at 90 °C. Upon addition, the off-white solution turned an opaque darkblue color. The top of the flask was continually heated with a heat gun to ensure all
sublimed benzoic acid would remain in contact with the solution. Once sublimation
ceased, the solution was heated to 150 °C for 24 hours. After 24 hours, GC/MS analysis
of an aliquot of the mixture indicated quantitative conversion. The reaction mixture was
then added dropwise to 600 mL of stirred water and the remaining solids were isolated
via filtration. The solids were then dissolved in ~250 mL EtOAc and washed with equal
volumes of Na2CO3 solution, water, and brine. The organic layer was dried over MgSO4,
filtered, and the EtOAc was removed in vacuo using a rotary evaporator to afford a
brownish-yellow solid. The solids were recrystallized from EtOH to afford a white
crystalline solid. Yield: 746 mg (38 %). GC/MS (m/z): 229.0 amu; m.p. 70-72 °C. 1HNMR (400 MHz, CDCl3): δ 7.21-7.24 (dt, 3JH-H, 3JF-H = 8.8 Hz; 4JH-H= 1.3 Hz, 1H), 7.31
(ddd, 3JH-H = 7.6 Hz; 4JF-H= 6.7 Hz; 4JH-H = 1.0 Hz, 1H), 7.41 (dt, 3JH-H = 7.6 Hz; 4JH-H =
1.0 Hz, 1H ), 7.45-7.47 (ddt, 3JH-H = 5.7 Hz; 4JF-H = 4.6 Hz; 4JH-H = 2.7 Hz, 1H), 7.52 (dt,
3

JH-H = 7.7 Hz; 4JH-H = 1.1 Hz, 1H), 7.94 (dd, 3JH-H = 8.2 Hz, 1H), 8.13 (dd, 3JH-H = 7.4 Hz,

1H), 8.42 (dt, 3JH-H = 7.6 Hz; 4JH-H = 1.5 Hz, 1H) ppm. 13C-NMR (100 MHz, CDCl3): δ
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116.7 (d, 2JC-F = 22.0 Hz), 121.6 (d, 2JC-F =10.7 Hz), 121.6, 123.5, 124.9 (d, 4JC-F = 3.9
Hz), 125.5, 126.5, 129.9 (d, 3JC-F = 2.8 Hz), 132.3 (d, 3JC-F = 8.7 Hz), 135.9 (d, 5JC-F = 8.0
Hz), 152.7, 160.7 (d, 1JC-F = 253.7 Hz), 161.2 (d, 3JC-F = 6.1 Hz) ppm. 19F-NMR (376.5
MHz, CDCl3): δ -111.9 (s) ppm.
4.2.1 Synthesis of 2-(2-fluorophenyl)-6-iodo-benzothiazole, 2-F-BTZ-I (3a)
In an oven-dried 10 mL RBF, equipped with a nitrogen inlet, and stir bar, were
placed 2-F-BTZ (0.500 g, 2.19 mmol) and 2 mL of H2SO4. A solution of Niodosuccinimide (0.699 g, 3.11 mmol) in 4 mL of H2SO4 was added dropwise. The
resulting mixture was stirred at room temperature for 24 hours at which point GC/MS
analysis of an aliquot precipitated from water indicated ~85% conversion to
monosubstituted product and a remaining 5 % of starting material. An additional 0.14
equivalents of NIS solution (0.0689 g, 0.306 mmol) were added, and the reaction was
stirred for another 24 h. After 24 hours, GC/MS analysis of an aliquot of the mixture
indicated ~82% conversion to monosubstituted product and 16% disubstituted product.
The reaction mixture was then added dropwise to 700 mL of stirred water with salt and
NaHCO3 solution, and the resulting precipitate was isolated via vacuum filtration. The
brown dried solid was collected and an attempt to purify through flash column
chromatography (DCM/hexanes 1:4, <0.5% methanol) and dried in vacuo with isolation
of a white, crystalline solid. The following are the fractional distributions of product
purification:
Fractions 1-20 (NIS: 2.5%, Mono: 64.9%, Di: 32.6%)
Fractions 21-58 (Mono: 93.4%, Di: 6.6%) 434.2 mg
Fractions 59-63 (NIS: 10.5%, Mono: 82.8%, Di: 6.7%)
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Fractions 64-77 (~100% NIS)
Yield: 434 mg (56%). GC/MS (m/z): 355.0 amu; m.p. 133-137 °C. 1H-NMR (400 MHz,
CDCl3): δ 7.22-7.23 (dt, 3JH-H, 3JF-H = 11.1 Hz; 4JH-H = 8.1 Hz, 1H) 7.32 (ddd, 3JH-H = 7.7
Hz, 1H), 7.48-7.52 (ddt, 3JH-H = 7.8 Hz; 4JF-H = 8.2 Hz; 4JH-H = 3.6 Hz, 1H), 7.79 (dd, 3JHH=

8.8 Hz; 4JH-H = 1.5 Hz, 1H), 7.85 (d, 3JH-H = 8.6 Hz, 1H), 8.28 (ds, 4JH-H = 1.2 Hz, 1H),

8.40 (dt, 3JH-H = 7.6 Hz; 4JH-H = 1.5 Hz, 1H) ppm. 13C-NMR (100 MHz, CDCl3): δ 89.8,
116.6 (d, 2JC-F = 21.7 Hz), 121.2 (d, 2JC-F = 11.7 Hz), 125.0 (d, 4JC-F = 2.9 Hz), 129.9 (d,
3

JC-F = 3.0 Hz), 130.1, 132.7 (d, 3JC-F = 8.9 Hz), 135.6, 136.7, 138.0 (d, 5JC-F = 9.2 Hz),

152.1, 160.8 (d, 1JC-F = 252.6 Hz), 161.7 (d, 3JC-F = 5.8 Hz), ppm. 19F-NMR (376.5 MHz,
CDCl3): δ -111.5 (s) ppm.
4.3.1 Synthesis of 2-(2-fluorophenyl)-6-(carbazol-9-yl)-benzothiazole, 2-F-BTZCBz (4a)
In an oven-dried 10 mL RBF, equipped with a nitrogen inlet, and stir bar, were
placed 2-fluorophenyl-iodo-benzothiazole (0.151 g, 0.425 mmol), CuI (0.0080 g, 0.042
mmol), N,N-dimethylglycine (0.0090 g, 0.087 mmol), K2CO3 (0.175 g, 1.27 mmol), and
~5 mL of DMSO. Following this, carbazole (0.215 g, 1.29 mmol) was added to the
stirring solution and heated to 90 °C over 24 hours. After 60 hours, GC/MS analysis of an
aliquot of the mixture indicated ~96% conversion to product. The reaction mixture was
then added dropwise to 200 mL of stirred water with salt and extracted with 200 mL of
hexanes from the water mixture. The organic layer revealed minimal product extracted
from water mixture, so 2x150 mL of EtOAc was used as an extractant from the water
mixture. These washes were combined, dried over MgSO4, filtered, and the EtOAc was
removed in vacuo using a rotary evaporator. The crude purity through GC/MS analysis
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revealed 71:29 carbazole to product. The remaining solids were recrystallized from
EtOH/H2O and triturated in hexanes with isolation of light brown solid ~100% purity.
Yield: 25.5 mg (15%). GC/MS (m/z): 394.1 amu; m.p. 155-160°C. 1H-NMR (400 MHz,
CDCl3): δ 7.28-7.30 (dt, 3JH-H, 3JF-H = 9.8 Hz; 4JH-H = 2.8 Hz, 1H), 7.31-7.35 (ddd, 3JH-H =
7.7 Hz; 4JF-H = 7.9 Hz; 4JH-H = 2.3 Hz, 1H), 7.36-7.39 (dt, 3JH-H = 7.3 Hz; 4JH-H = 1.1 Hz,
2H), 7.44-7.47 (m, 4H), 7.49-7.55 (ddt, 3JH-H = 8.1 Hz; 4JF-H = 11.2 Hz; 4JH-H = 1.8 Hz,
1H), 7.72 (dd, 3JH-H = 8.8 Hz; 4JH-H = 2.1 Hz, 1H), 8.14 (ds, 4JH-H = 1.6 Hz, 1H), 8.18 (dd,
3

JH-H = 7.8 Hz; 4JH-H = 1.0 Hz, 2H), 8.32 (d, 3JH-H = 8.7 Hz, 1H), 8.49 (dt, 3JH-H = 7.4 Hz;

4

JH-H = 1.7 Hz, 1H) ppm. 13C-NMR (100 MHz, CDCl3): δ 109.9, 116.7 (d, 2JC-F = 21.8

Hz), 120.1, 120.4, 120.6, 121.4 (d, 2JC-F = 10.7 Hz), 123.7, 124.5, 125.0 (d, 3JC-F = 2.9
Hz), 126.0, 126.3, 129.9 (d, 4JC-F = 2.9 Hz), 132.7 (d, 3JC-F = 8.4 Hz), 135.2, 137.2 (d, 5JCF

= 9.1 Hz), 141.2, 151.8, 160.8 (d, 1JC-F = 253.2 Hz), 162.3 (d, 3JC-F = 5.8 Hz) ppm. 19F-

NMR (376.5 MHz, CDCl3): δ -108.7 (s) ppm.
5.1 Synthesis of 2-(4-fluorophenyl)-benzothiazole, 4-F-BTZ (2c)
In an oven-dried 250 mL RBF, equipped with a nitrogen inlet, water condenser,
and stir bar, were placed 4-fluoro-benzoic acid (0.722 g, 5.15 mmol) and poly(phosphoric
acid) (~12 g). The mixture was heated and stirred at 90 °C until the benzoic acid was fully
dissolved. Following this, 2-aminothiophenol (0.55 mL, 5.1 mmol) was added to the
stirring solution at 90 °C. Upon addition, the off-white solution turned an opaque darkgreen color. The top of the flask was continually heated with a heat gun to ensure all
sublimed benzoic acid would remain in contact with solution. Once this ceased, the
solution was heated to 150 °C for 24 hours. After 24 hours, GC/MS analysis of an aliquot
of the mixture indicated quantitative product formation. The reaction mixture was then
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added dropwise to 700 mL of stirred water and filtered off remaining solids. The solids
were then dissolved in ~200 mL EtOAc and washed with equal volumes of NaHCO3
solution, water, and brine. The organic layer was dried over MgSO4, filtered, and the
EtOAc was removed in vacuo using a rotary evaporator to afford a blue-purple solid.
Recrystallization from EtOH/H2O failed, so the solvent was removed and dried over a
vacuum line with isolation of blue-purple crystalline solid. Yield: 601 mg (51%). GC/MS
(m/z): 229.2 amu; m.p. 88-89 °C. 1H-NMR (400 MHz, CDCl3): δ 7.19 (t, 3JH-H, 3JF-H =
8.5 Hz, 1H), 7.39 (dt, 3JH-H = 7.7 Hz; 4JH-H = 1.2 Hz, 1H), 7.50 (dt, 3JH-H = 7.4 Hz; 4JH-H =
1.3 Hz, 1H), 7.91 (dd, 3JH-H = 8.0 Hz; 4JH-H = 1.2 Hz, 1H), 8.06 (dd, 3JH-H = 8.3 Hz; 4JH-H =
1.2 Hz, 1H), 8.08-8.10 (dd, 3JH-H = 8.0 Hz; 4JF-H = 9.0 Hz, 1H) ppm. 13C-NMR (100 MHz,
CDCl3): δ 116.3 (d, 2JC-F = 22.1 Hz), 121.8, 123.3, 125.4, 126.5, 129.7 (d, 3JC-F = 9.3 Hz),
130.1 (d, 4JC-F = 3.6 Hz), 135.2, 154.3, 164.6 (d, 1JC-F = 252.7 Hz), 166.9 ppm. 19F-NMR
(376.5 MHz, CDCl3): δ -108.9 (s) ppm.
5.2 Synthesis of 2-(4-fluorophenyl)-6-iodo-benzothiazole, 4-F-BTZ-I (3c)
In an oven-dried 15 mL RBF, equipped with a nitrogen inlet, and stir bar, were
placed 2-(4-fluorophenyl)-1,3-benzothiazole (0.502 g, 2.19 mmol) and 2 mL of H2SO4. A
solution of N-iodosuccinimide (0.393 g, 1.75 mmol) in 4 mL of H2SO4 was added,
dropwise via an addition funnel over the course of an hour, to the 4-F-BTZ solution. The
resulting mixture was stirred at room temperature for 2 hours at which point GC/MS
analysis of an aliquot precipitated from water indicated ~60% conversion. GC/MS
analysis was also used to observe the conversion over 4 and 24 hours, which also
revealed the same ~60% conversion to monosubstituted product and respective starting
material and byproduct. This confirmed that the reaction is completed ≤2 hours upon
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addition. An additional 0.2 equivalents of NIS solution (0.0972 g, 0.432 mmol) added
dropwise via an addition funnel over the course of an hour. The resulting mixture was
stirred at room temperature for 16 hours at which point GC/MS analysis of an aliquot
precipitated from water indicated ~71% conversion. An additional 0.2 equivalents of NIS
solution (0.0977 g, 0.434 mmol) added dropwise via an addition funnel over the course of
an hour. The resulting mixture was stirred at room temperature for 2 hours at which point
GC/MS analysis of an aliquot precipitated in water indicated ~81% conversion. An
additional 0.1 equivalents of NIS solution (0.0482 g, 0.214 mmol) added dropwise via an
addition funnel over the course of an hour. The resulting mixture was stirred at room
temperature for 1 hour at which point GC/MS analysis of an aliquot precipitated in water
indicated ~85% conversion. The reaction mixture was then added dropwise to 700 mL of
stirred water, and the resulting precipitate (597 mg) was isolated via vacuum filtration
affording an 88% crude yield. The brown dried solid was dissolved in toluene (~150 mL)
and transferred to a 500 mL separatory funnel. The organic layer was washed with equal
volumes of 5% NaHCO3 solution, DI water, and brine. The organic layer was dried over
MgSO4, filtered, and the dichloromethane was removed in vacuo using a rotary
evaporator to afford an orange-red solid. The remaining solids were recrystallized from
EtOH/H2O to yield ~99% monosubstituted pink solid product. To remove possible excess
NIS, the solid was dissolved in CHCl3 (~70 mL) and washed with 10% bisulfite solution.
The CHCl3 was removed in vacuo using a rotary evaporator with isolation of a light pink
solid ~99% purity. Yield: 306 mg (39 %). GC/MS (m/z): 355.0 amu; m.p. 165-167 °C.
1

H-NMR (400 MHz, CDCl3): δ 7.19 (dd, 3JH-H, 3JF-H = 8.6 Hz, 2H), 7.78 (m, 2H), 8.07

(dd, 3JH-H = 8.8 Hz; 4JF-H = 8.8 Hz, 2H), 8.23 (ds, 4JH-H = 2.2 Hz, 1H) ppm. 13C-NMR
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(100 MHz, CDCl3): δ 89.5, 116.3 (d, 2JC- F = 23.4 Hz), 124.6, 129.4 (d, 4JC-F = 3.5 Hz),
129.6 (d, 3JC-F = 8.6 Hz), 130.1, 135.6, 137.1, 153.5, 164.7 (d, 1JC-F = 249.7 Hz), 167.2
ppm. 19F-NMR (376.5 MHz, CDCl3): δ -108.2 (s) ppm.
5.3 Synthesis of 2-(4-fluorophenyl)-6-(carbazol-9-yl)-benzothiazole, 4-F-BTZCBz (4c)
In an oven-dried 15 mL RBF, equipped with a nitrogen inlet, and stir bar, were
placed 2-(4-fluorophenyl)-6-iodo-benzothiazole (0.201 g, 0.567 mmol), CuI (0.0176 g,
0.0924 mmol), N,N-dimethylglycine (0.0177 g, 0.172 mmol), K2CO3 (0.236 g, 1.71
mmol), carbazole (0.276 g, 1.65 mmol) and ~5 mL of DMSO. The resulting mixture was
stirred at 90 °C for 12 hours, at which point GC/MS analysis of an aliquot of the mixture
indicated ~99% conversion and a 3:2 CBZ to 4-F-BTZ-CBZ ratio. The reaction mixture
was then added dropwise to 250 mL of stirred water, and the resulting precipitate (192
mg) was isolated via vacuum filtration. The off-white dried solid was dissolved in
chloroform (~50 mL) and transferred to a 125 mL separatory funnel and washed with
2x50 mL DI water. The organic layer was dried over MgSO4, filtered, and the chloroform
was removed in vacuo using a rotary evaporator. The remaining solids were
recrystallized from EtOH/H2O with isolation of a light brown crystalline solid ~100%
purity. Yield: 99 mg (44%).GC/MS (m/z): 394.2 amu; m.p. 167-169 °C. 1H-NMR (400
MHz, CDCl3): δ 7.21-7.26 (t, 3JH-H , 3JF-H = 7.6 Hz, 2H), 7.30-7.34 (dt, 3JH-H = 7.6, 4JH-H
=3.5 Hz, 2H), 7.43-7.44 (m, 4H), 7.70 (dd, 3JH-H = 8.8 Hz, 4JH-H =2.0 Hz, 1H), 8.10 (ds,
4

JH-H = 1.7 Hz, 1H), 8.12-8.16 (dd, 3JH-H = 7.9 Hz, 4JF-H = 8.8 Hz, 2H), 8.17 (dd, 3JH-H =

8.3 Hz, 4JH-H = 1.1 Hz, 2H), 8.26 (d, 3JH-H = 8.5 Hz, 1H) ppm. 13C-NMR (100 MHz,
CDCl3): δ 109.7, 116.4 (d, 2JC-F = 21.0 Hz), 120.1, 120.2, 120.4, 123.5, 124.2, 126.0,
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126.1, 129.66 (d, 3JC-F = 9.4 Hz), 129.75 (d, 4JC-F = 3.4 Hz), 135.0, 136.1, 141.1, 153.2,
164.7 (d, 1JC-F = 251.4 Hz), 167.8 ppm. 19F-NMR (376.5 MHz, CDCl3): δ -111.7 (s) ppm.
6.1 Synthesis of HPEI-IBAm0.61-2-(4-phenyl)-6-(carbazol-9-yl)-benzothiazole,
HPEI-IBAm0.61-BTZ-CBz (8)
In an oven-dried 15 mL RBF, equipped with a nitrogen inlet, and stir bar, were
placed 2-(4-fluorophenyl)-6-(carbazole-9-yl)-1,3-benzothiazole (0.0300 g, 0.0761 mmol),
HPEI-IBAm0.61 (0.746 g, 10.0 mmol), K2CO3 (0.0159 g, 0.115 mmol), and ~2 mL
DMSO. The resulting mixture was stirred at 110 °C for 48 hours. The reaction mixture
was added dropwise to 100 mL of stirred water, and extractions of CHCl3 and EtOAc
were performed with 2x equal volumes of each on the aqueous layer. The organic layer
was dried, filtered, was removed in vacuo using a rotary evaporator to afford minimal
off-white solid. 1H and 13C NMR analysis revealed no significant conversion to product,
so the aqueous layer was analyzed through 1H and 13C NMR after drying in vacuo and on
the vacuum line to remove residual water and DMSO. NMR analysis demonstrated
conversion, which lead to redissolving the sample in HQ H2O and subjecting the mixture
through dialysis for 48 hours. After the dialysis sample was filtered, HQ water was
removed in vacuo using a rotary evaporator and the resulting orange oil was analyzed
through 1H NMR analysis shown in Appendix: Supplemental Figure 48.
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III.

Results & Discussion

The first phase of the project was to prepare the synthetic gene vector to which the
eventual blue emitting chromophores will be attached. Polyethylene imine (PEI) is a
water soluble, polycation that has been used previously as a gene delivery vector. Our
group has modified its structure by the addition of various hydrophopic groups, thereby
creating a dual stimuli, pH and temperature, vector that might enhance gene delivery. The
ratio of primary, secondary, and tertiary amines in HPEI is approximately 1:1.20:0.76,
thus, 73% of the repeat units are “modifiable.” This being the case, only primary and
secondary amine groups are modifiable, while tertiary amine groups are not considered in
the reaction. Scheme 2 demonstrates the conversion of HPEI to HPEI-IBAm.60 through the
amidation of HPEI with iso-butyryl chloride. Through the synthesis of HPEI-IBAm0.60,
an adequate amount of the primary and secondary groups should be spared for further
modification. Equations 4-6 demonstrate the calculation of the percentage amidation of
HPEI through integration propagation in 1H NMR.
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Scheme 2. Hyperbranched poly(ethylenimine)(6) with iso-butyryl chloride yielding amidated hyperbranched
poly(ethylenimine)(7).

In theory, each primary and secondary amine should have the potential to attacked
by the iso-butyryl chloride, which equates to 73% when dissecting the ratios of primary,
secondary, and tertiary amines. The abundance of primary, secondary, and tertiary
amines within the configuration of hyperbranched poly(ethylenimine) is approximately
1:1.20:0.76, respectively, which ultimately provides a theoretical value of 73% of the
amines as potential substitution sites. However, leaving unreacted amines to be utilized
for sequential additions such as fluorescent tagging or addition alkyl chain attachments is
beneficial. Therefore, the more realistic ratio of 60% amidation as opposed to the
possible 73% is preferred. Any primary amines that remain also have the potential to be
alkylated or pegylated twice. These ratios can be determined through a proportional
analysis of an integrated 1H NMR spectrum represented by Figure 9, where there is a
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great amount of overlay with proton peaks because of similar relaxation times within the
polymer backbone.

b+c+d+e+f+g+h+i

f

e
g
h

d
c

i

b
a
a

Figure 9. 1H NMR (300 MHz, D2O) of the amidated product of hyperbranched poly(ethylenimine) (7).

The second phase of the project was the development of a series of benzothiazole
based chromophores designed to undergo TADF emission with a focus on blue. The
synthetic route involved three different steps as outlined in Schemes 2-4. Scheme 3
depicts the general reaction conditions for the initial benzothiazole synthesis of 2a-c,
which involved the reaction of appropriated substituted benzoic acids with orthoaminothiophenol in poly(phosphoric acid) (PPA) that serves as a catalyst and the solvent.

Scheme 3. Synthesis with fluoro-benzoic acid derivatives (1a-c) with 2-amino-thiophenol in 84% poly(phosphoric acid)
from 90 °C to prevent all benzoic acid from subliming to 150 °C for 24 h to form 2-(fluorophenyl)-1,3-benzothiazole
derivatives (2a-c).
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Iodination of the benzothiazoles was carried with N-iodosuccinimide (NIS) in
sulfuric acid as shown in Scheme 4. Theoretically, the electrophilic aromatic substitution
reaction will occur para to the nitrogen. Electronically, this is where the most stable
carbocation intermediate will form. Sulfuric acid protonates the carbonyl site on NIS, and
through resonance, will generate, essentially, I+ as the required electrophile.

Scheme 4. Synthesis with fluorophenyl-benzothiazole derivatives (2a-c) with N-iodosuccinimide in sulfuric acid at
room temperature to form 2-(fluorophenyl)-6-iodo-1,3-benzothiazole derivatives (3a-c).

The final step in the synthetic route involves replacing the iodo group with the
desired donor group, carbazole, using a CuI catalyzed Ullmann type C-N coupling
reaction as shown in Scheme 5. The addition of base deprotonates carbazole to promote
the substitution of iodine with carbazole at that site.

Scheme 5. Synthesis with 2-(fluorophenyl)-6-iodo-1,3-benzothiazole derivatives (3a-c) with carbazole, catalyst, ligand,
and base in DMSO at 95 °C to form 2-(fluorophenyl)-6-(carbazol-9-yl)-1,3-benzothiazole derivatives (4a-c).

Figure 10 is the 1H NMR for compound 2c with the respective proton associated
to the structure shown. Protons ortho to electron withdrawing inductive characteristics
but electron donating resonating effects will shift protons up-field while meta protons
will shift far downfield. This is the case with labels a and b next to the fluorine atom para
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to the benzothiazole. The cyclic nitrogen within the benzothiazole ring promotes
resonance pushing, which shields protons c and d downfield compared to protons f and e
closer to the cyclic sulfur. All protons within the system are involved in some variation of
advanced coupling. As an example, proton c not only is coupled to d to produce a
doublet, but this is meta coupled to proton e and para coupled to proton f. This would
induce c to be a “doublet of doublet of doublets” but may only appear as a doublet of
doublets when viewing the spectrum. Depending on the MHz and shimming of the
instrument, these advanced splittings can be observed. In this case, these J coupling
values are observed and be tabulated simply by taking the difference in Hz peak values.
The proper notation of J coupling is the bond number in the superscript and the
classification of splitting in the subscript. Proton c couples to d calculates 3JH-H at 8.3 Hz
and coupling to e calculates 4JH-H at 1.2 Hz.
Ideally, proton to proton ortho coupling ranges from 7-10 Hz, meta coupling
ranges from 1-3 Hz, and para coupling is <1 Hz. Typically, para splittings are not
observed based off the shimming precision of the instrument. This differs when involving
fluorine coupling because 19F is so readily abundant and, since the isotope is NMR active,
fluorine will induce advance splitting similar to proton atoms. These J splitting values are
generally much larger for ortho and meta J coupling constants and even can demonstrate
some para splitting. In addition to the theoretical shifting patterns and coupling
calculations, the integrations validate the proton assignments with exceptions to some
peak overlap.
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Figure 10. 1H NMR (400 MHz, CDCl3) spectrum of 4-F-BTZ (2c) (*CHCl3).

Figure 11 represents compound 3c, which alters the splitting on protons c, d, and f
in terms of chemical shift and splitting. Protons a and b are similar to that of Figure 10
because the iodination does not electronically surpass through the benzothiazole ring.
Although c experiences electron delocalization from the nitrogen, it also experiences
deshielding effects from the iodone atom situation meta in position. Proton d will shift in
a similar manner by shifting downfield being ortho to iodine, and will overlay with
proton c. The splitting for f will be represented as a singlet, but possible endure meta
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coupling effects along with downfield shifting because of being deshielded by iodine and
sulfur atoms.
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Figure 11. 1H NMR (400 MHz, CDCl3) spectrum of 4-F-BTZ-I (3c) (*CHCl3).

Figure 12 has much more complexity with the additional carbazole substitution, to
which there is much more overlap with proton chemical shifts. Considering that there is
not much interaction across the benzothiazole ring, carbazole addition will not
dramatically affect the shifts of protons a and b, but will overlay with the additional
protons within the carbazole moiety. Similar to Figure 10 and Figure 11, many protons
are subjected to cross coupling across aromatic rings. This is evident with protons c-j in
their new electronic environments in addition to the unaffected protons a and b. Within
the carbazole moiety, electron delocalization is prominent, but is selective on which
positions protons are situated, such as the intense downfield shift of proton j that overlays
with proton b. This differs from neighboring protons g-i because they are considered to
be more shielded nearest to the centralized nitrogen. These peaks can be differentiated
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through J value calculations but can be challenging when the peaks are overlayed. This is
another instance where integrations are essential to identify chemical shifts when the
spectrum appears much more complex.
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Figure 12. 1H NMR (400 MHz, CDCl3) spectrum of 4-F-BTZ-CBz (4c) (*CHCl3).

In order to confirm the proton assignments for the structure of 4c in Figure 12 above, a
2D 1H-1H COSY NMR spectrum was performed to observe the coupling signals shown
in Figure 13. 2D 1H-1H COSY NMR allows for the coupling of protons that are
neighboring to be viewed in horizontal and vertical projections. The field can be
intensified to view lesser intense cross couplings across aromatic rings if they are in
phase with one another.
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Figure 13. 1H-1H COSY NMR (400 MHz, CDCl3) 2D spectrum of 4-F-BTZ-CBz (4c).

An additional confirmation of purity of products is preforming 13C NMR
spectroscopy. These experiments take in account of the proton positions and can indicate
carbon relaxations, which are correlated with the intensities of the peaks. This is the
reasoning why quaternary carbons are much less intense than primary, secondary, or even
tertiary carbons. 13C NMR is especially useful when overlaying stacked spectra for
compounds with slight structural differences. Figure 14 is a stacked overlay for
compounds 2-4c to observe carbon chemical shifts of different moiety additions.
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Figure 14. 13C NMR (100 MHz, CDCl3) stacked spectra within the aromatic region of 4-F-BTZ-CBz (4c, blue), 4-FBTZ-I (3c, red), and 4-F-BTZ (2c, green).

As demonstrated in Figure 14, there are peaks that are quite apparent that define
each compound clearly and others that are congruent with each compound (2-4c). It is
notable that 19F will induce splitting within the carbon spectrum due to 19F is near 100%
abundant and is NMR active and will induce coupling producing different relaxation
times of neighboring carbons. The ipso carbon is considered to have the largest J
coupling because of the electronic resonance being greatest and free from neighboring
interferences. As the bond number increases from the fluorine atom, the J value
diminishes because there less of a splitting effect from the active NMR coupling 19F. In
addition, 19F lacks electron occupation in d orbitals, which promotes electron
withdrawing properties that de-shield neighboring carbon atoms. Because of this, carbons
are shifted far down-field compared to carbons near the benzothiazole ring. The 4-F
series is a more simplistic model to view carbon splittings since it is the most
symmetrical species amongst the benzothiazole series synthesized.
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In addition to the fluorine fingerprints on peaks, there are also strong indications
that are unique in specific compounds. One of which is the ipso carbon from iodine on
compound 3c. Iodine does not behave similarly to 19F because it is not NMR active with
its primary abundant isotope, so it does not induce splitting. Iodine has more occupied d
orbitals, therefore a larger interaction with carbon shielding, which is the explanation for
the dramatic up-field shift of the ipso carbon, h. The ortho carbons will experience more
de-shielding effects as a result and will shift up-field compared to the 2c compound. This
can also be compared to the 4c compound, where there is an iodo moiety is replaced with
a carbazole donor. This effect can be seen by up-field shifting of carbons that do not have
extraneous interferences of other neighboring atoms, such as nitrogen. Carbons h and g
have an apparent chemical shift in 4c compared to 2c, but this does not correlate to i
because of the nitrogen environment influence on the benzothiazole ring.
Figure 15 demonstrates the 1H NMR spectrum of compound 2b, which is slightly
more complex than compound 2c, since it is more asymmetric. Because of the shim
processing of the 300 MHz NMR, the advanced splitting was much more apparent with
meta and even some para coupling. Tabulating J values, integrating, and reasoning
chemical shifts allowed for assignment of protons a-h.
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Figure 15. 1H NMR (300 MHz, CDCl3) spectrum of 3-F-BTZ (2b) (*CHCl3).

Figure 16 represents the 1H NMR spectrum of compound 3b, which demonstrated
much more overlay in chemical shifts compared to compound 3c. The additional
couplings of the fluoro-phenyl moiety increase the probability of similar shifts to the
benzothiazole proton shifts. From this, it is challenging to calculate J values with massive
overlays, so relying on propagation of chemical shifts and integrations is necessary. This
is especially seen in protons c, d, h, and g, as opposed to a, b, and e having clear
separations and tabulated J values due to their unique environments.
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Figure 16. 1H NMR (400 MHz, CDCl3) spectrum of 3-F-BTZ-I (3b) (*CHCl3).

The complexity in proton shifts in Figure 17 for compound 4b is similar to that of
Figure 12 because of the additional carbazole substitution. The process for proton
assignment is similar, although there was not a 2D 1H-1H COSY scan to assist in
identifying peaks. Since there is not much of a chemical shift influence across the
benzothiazole ring, protons within carbazole are analogous to compound 4c depicted
previously. However, the probability of overlay was still prominent, so this adds to the
complication of proton assignments.
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Figure 17. 1H NMR (300 MHz, CDCl3) spectrum of 3-F-BTZ-CBz (4b) (*CHCl3).

An additional confirmation is also performed on the purity of compounds 2-4b
through 13C NMR in Figure 18, where very similar trends seen in Figure 14 with fluoro
and iodo moieties. Considering that the fluorine is in a position that influences
asymmetrical chemical shifts within the fluoro-phenyl substituent, there are not only
more peaks present but more apparent peak splitting. The ipso carbon, b, remains at very
similar splitting and chemical shift to 2-4c compounds, but induces different ortho
chemical shifts on carbons a and c. Carbon a experiences more electron shielding effects
due to its proximity to the benzothiazole, while c does not experience these effects.
Because of this, proton a is more up-field than c. Differentiating the assignments strictly
by 19F splitting is not as effective since they should have near identical splitting patterns.
The same methodology is employed with the induced splitting carbons within the fluorophenyl moiety in terms of J tabulations and theoretical chemical shifts based off
environments.
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Figure 18. 13C NMR (100 MHz, CDCl3) stacked spectra within the aromatic region of 3-F-BTZ-CBz (4b, blue), 3-FBTZ-I (3b, red), and 3-F-BTZ (2b, green).

Figure 19 depicts the 1H NMR spectrum of compound 2a, which has a similar
chemical shift and coupling to Figure 16. This allows for more definitive shifts since
there is only one proton that is ortho to the fluorine atom, which limits the amount of
overlap of peaks. Proton c will experience the most down-field shift because it is para to
the fluorine atom. It can be deduced that this is most de-shielded position of the fluorophenyl ring when compared to the meta shielded protons b and d along with a being
ortho to fluorine. Proton d experiences resonance with the neighboring nitrogen, which
contributes to shielding effects compared to b. The benzothiazole ring protons remain at
similar chemical shifts compared to Figure 16, which makes assignments easy to
decipher.
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Figure 19. 1H NMR (400 MHz, CDCl3) spectrum of 2-F-BTZ (2a) (*CHCl3).

Figure 20 represents the 1H NMR spectrum of compound 3a, which displays more
of a separation of peaks because of the fluoro position. The ortho proton, a, experiences a
shielding effect from resonance but de-shielding effects on the para proton, c. Protons g
and h experience more chemical separation due to a slight influence from the fluorine
across the benzothiazole ring, even though this is very minimal. The integrations can also
confirm the validity of J values and theoretical chemical shifts based off environment.

59

e

a

*

h

b
c

d

h

g
e

g
d

c
a
b

Figure 20. 1H NMR (400 MHz, CDCl3) spectrum of 2-F-BTZ-I (3a) (*CHCl3).

Figure 21 represents the 1H NMR spectrum of compound 4a, which is similar in
complexity to Figure 17 in terms of peak overlay. The protons within the carbazole
substituent are not shifted by the fluoro positioning dramatically but experience an
overlay with the fluoro-phenyl protons.
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Figure 21. 1H NMR (400 MHz, CDCl3) spectrum of 2-F-BTZ-CBz (4a) (*CHCl3).

An additional confirmation is also performed on the purity of compounds 2-4a
through 13C NMR in Figure 22, which is similar in peak distribution to Figure 18. A
major difference arises from the fluoro positioning because of the difference in
environments for carbons ortho to the fluorine atom. Carbon b experiences the typical
shielding from fluorine, but carbon f has an influence of both fluorine and benzothiazole
moieties. Another unusual phenomenon within the 2-4a series is the induced splitting
from fluorine at carbon h and not carbon m. The configuration of the fluoro-phenyl
substituent should allow for rotating in and out of plane with the rest of the molecule, but
this does not seem to have an interference with m. Fluorine can resonate more readily
through double bonds, which can indicate why h contains a J coupling constant.
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Figure 22. 13C NMR (100 MHz, CDCl3) stacked spectra within the aromatic region of 2-F-BTZ-CBz (4a, blue), 2-FBTZ-I (3a, red), and 2-F-BTZ (2a, green).

A special type of 13C NMR spectroscopy experiment can be utilized to identify
carbon atoms that have protons attached to them, as well as those that don’t. The 13C
DEPT90 NMR spectrum of compound 2a will only give rise to peaks for carbon atoms
with one proton attached through a process of polarization transfer. DEPT stands for
differential enhancement by polarization transfer and, essentially, uses the attached
protons to enhance the signal intensity for the corresponding carbon atoms. From this,
the DEPT90 scan will not have signals for carbons a, f, g, h, and m, and this can be
conclusive when paired with theoretical chemical shift values. It is also helpful to utilize
the fluorine splitting characteristics to denote proper assignments.
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Figure 23. 13C DEPT90 NMR (100 MHz, CDCl3) of 2-F-BTZ 13C scan (blue) and 2-F-BTZ DEPT90 scan (red)
representing only 1°, 2°, and 3° carbons (2a).

Another method to ensure purification of compounds is gas-chromatography mass
spectrometry (GC/MS), which will observe the retention times and correlates peaks
within the gas chromatogram with masses of the base cation along with its various
fragments. The solution, typically suspended in acetone, enters a column within a PDMS
stationary phase coating, to which nonpolar components will have a lower retention than
polar components. This promotes the separation of peaks within a given spectral scan.
Figure 24 is an example of compound 3a and a common di-iodinated byproduct before
purification steps.
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Peak 1

Peak 2

Figure 24. GC/MS chromatogram and percentage report for 2-F-BTZ-I (3a) crude product pre-purification.

The GC/MS data presented in Figure 24 indicates the presence of multiple
iodinated products. With a temperature ramp of 10 °C/min from 150-250 °C, the peak at
6.42 min, with m/z of 355.0, is mono-iodinated compound, while the peak at 8.28 min.,
with m/z of 481.9, is a di-iodinated compound. GC/MS can also separate isomers of
iodinated materials. This is demonstrated with the peak range from 6.30-6.42 min which
comprises of a small ratio mono-iodinated isomers with a slight increase in polar
characteristics. This is similar to the di-iodinated compounds that also consist of isomers
with varying polarities. The series of peaks from 8.00 to 8.28 minutes all have m/z values
of 481.9 correspond to di-iodinated species. This alludes to the polarity differences that
can be utilized to separate the compounds at a large scale. Despite slight polarity
differences, this does not contribute to a guaranteed purification method through
analyzing polarity alone. Separation on GC/MS is also accredited by the mass of the
specific analytes. As the mass increases of a particular substance, the analyte will
experience a longer retention time within the column. The ease of purification is strongly
dictated by the percentages of mono- to di-substituted materials present, along with the
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similarity of their retention time, even though this fluctuates upon the ramp setting.
Obstacles with separation of mixtures of similar polarities promotes the largest
contribution of yield lost in a synthesis.
This contrasts the conditions for substitution of iodine with the carbazole donor
moiety. In order to push the reaction to completion, 3 eq of carbazole must be present to
perform nucleophilic substitution with iodine, which indicates that there is an excess of
carbazole remaining even after full conversion to product. Figure 25 is a GC/MS scan of
an aliquot that was a pre-purified sample of synthesis 4a with a percentage report of the
reagents remaining within the mixture.

Figure 25. GC/MS chromatogram and percentage report for 2-F-BTZ-CBz (4a) crude product pre-purification.

Similar to the 3a synthesis, different isomeric compounds exist at similar
retention times, which indicates a slight variance in polarity. However, the separation of
retention times at the same ramp and temperature conditions indicates much more of a
polarity separation between starting material, byproduct, and projected product. This is
also attributed to the mass difference of the varying analytes within the mixture.
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Depending on the ratios of the contents within the mixture, this can potentially grant a
more successful purification process than iodination workups.
More feasible comparisons of compounds 4a-c through stacked 13C NMR spectra
in Figure 26 can be made when observing differences in chemical shifts of these
geometric isomers.
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Figure 26. 13C NMR (100 MHz, CDCl3) stacked spectra within the aromatic region of 4-F-BTZ-CBz (4c, blue), 3-FBTZ-CBz (4b, red), and 2-F-BTZ-CBz (4a, green).

Besides the number of peaks represented by each scan, there are several
similarities between derivatives that are present in stacked comparison between 4a-c.
There is a noticeable change in the average chemical shift in the ipso carbons to fluorine,
but the J values tabulated for 4a as 253.2 Hz, 4b as 246.9 Hz, and 4c as 251.4 Hz, which
are comparable. The major difference is the neighboring carbons surrounding this
fluorine atom along with the induced splitting values. This also alludes to the differences
in electron delocalization within the 4a-c species, which also can be distinguished as
different wavelengths of emission from the donor carbazole to acceptor benzothiazole
66

moieties. For example, 4c experiences more of a down-field chemical shift because of
greater de-shielding characteristics. Greater de-shielding characteristics at the ipso
carbon, a, indicate greater shielding at the ortho, b. This can be observed when
comparing ipso and ortho assignments on compounds 4a and 4b, to which they do not
shift nearly as far down-field or up-field, respectively.
Another useful tool for analyzing differences of species between chromophore
derivatives is 19F NMR. Since 19F is so relatively abundant, strong signals are produced
and can denote if there are disubstituted impurities still present within the sample. Figure
27 represents the 19F NMR of compounds 4a-c and the chemical shift differences of each
derivative.

Figure 27. 19F NMR (376.5 MHz, CDCl3) stacked spectra of 4-F-BTZ-CBz (4c, blue), 3-F-BTZ-CBz (4b, red), and 2-FBTZ-CBz (4a, green).

The 19F NMR data is a measure of electron density of the ipso carbon atom to the
fluorine. This suggests that the data is in the perspective of the carbon atom that can be
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tuned through the placement of the fluorine atom in reference to the electron withdrawing
benzothiazole group. This alludes to reactivity at the ipso carbon in some compounds
than others in terms of sequential NAS synthesis with fluorine being the leaving group.
As a signal is shifted downfield, this indicates that the site is de-shielded, which is
stimulated by neighboring atoms with electron withdrawing properties. Fluorine is
considered to be both inductively withdrawing and resonantly donating, but this is paired
with the electron withdrawing effects of benzothiazole.
Because of its electron resonance, benzothiazole is a strong ortho and para
director. This indicates that depending on the fluorine substitution on the phenyl ring, the
de-shielding effects on carbon can be altered, which directly relates to the reactivity for
subsequent syntheses. As shown in Figure 27, 4c experiences both inductive and
resonance effects to the ortho/para positions based off its structure and influences more
of an intense dipole with the donor carbazole group. On the other hand, the 4b is on the
meta position, which eliminates resonance effects on the benzothiazole ring leaving only
inductive characteristics. These characteristics are similar to the 4a compound due to its
steric effects with its configuration. Although the fluorine exists in the ortho position, this
permits the fluorine to be rotated out of the plane with the benzothiazole moiety. Because
of this, there a lack of resonance to the benzothiazole, which leads to only inductive
characteristics.
19

F NMR data not only reveals information on reactivity, but there is also a strong

correlation on energy characteristics in terms of emission. Changing the position of the
fluorine clearly changed the reactivity to the rest of the system that remained constant in
structure. This implies that the benzothiazole ring is the acceptor to the carbazole donor
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based off the fluctuating reactivity correlating to fluorine position. This is also confirmed
through UV-Vis and fluorescence spectroscopy of the different chromophore derivatives.
Figure 28 depicts the UV-Vis spectrum of 4a-c chromophore derivatives to observe the
HOMO/LUMO gap along with excitation absorbances at higher energy levels.
Upon confirmation of the structures for the desired chromophores, the
optoelectronic properties were investigated through a combination of UV/Vis and
fluorescence spectroscopy techniques. Figure 28 depicts the UV-Vis spectra of the 4a-c
chromophore analogues to observe the HOMO/LUMO gap along with excitation
absorbances at higher energy levels, but there is also a strong correlation on energy
characteristics in terms of emission. Changing the position of the fluorine clearly changed
the reactivity to the rest of the system that remained constant in structure. This implies
that the benzothiazole ring is the acceptor to the carbazole donor based off the fluctuating
reactivity correlating to fluorine position. This is also confirmed through UV-Vis and
fluorescence spectroscopy of the different chromophore derivatives. The full spectrum
depicts not only the HOMO/LUMO gap, but also higher energy excitation absorbances at
higher energy levels. The HOMO/LUMO gap can often be inferred by the minimal
absorbance level that can be tabulated from the baseline near the 400 nm wavelength.
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Figure 28. UV-Vis spectrum between 250-400 nm of compounds 4a-c to observe the absorbances of various excited
transitions.

The broadness and peak variance between 4a-c can be attributed to different
charge transfer transitions between excited states. The carbazole donor group is
considered to be a “subunit”, as is the benzothiazole acceptor. At particular energies, the
subunits themselves will have specific absorbances.35 Similar substructures between
species indicates similar absorbances in their excited states. Since 4a and 4c contain
fluorine is the ortho and para positions meaning similar electron delocalization patterns,
these produce similar charge transfer absorbances unlike 4b in the meta position.
Figure 29 represents the range between 290-400 nm to identify the
HOMO/LUMO gap near the higher wavelength tail of the absorbance spectrum. It is
notable that the broad 310-400 nm region has a few apparent peaks, which is indicative of
multiple electronic transitions that overlap in their absorbance values.
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Figure 29. UV-Vis spectrum between 290-400 nm of compounds 4a-c to observe the absorbances of various excited
transition nearest to the HOMO/LUMO gap.

After UV-Vis was preformed, this gave an indication of what excitation
wavelength to measure fluorescence emission shown in Figure 30. Typically, the
wavelength region is scanned ~10nm above the excitation source wavelength. The
intensities of compounds 4a-c were normalized in order to compare fluorescence
emission wavelengths with one another. Compounds 4a and 4c were repeated and the
intensities were summed to enhance signal to noise ratio. It is important to note that the
wavelength of excitation will not shift the wavelength of emission, as long as the
emission is encompassed by the spectral scan range and excitation wavelength is below
the HOMO/LUMO wavelength.
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Figure 30. Fluorescence emission spectrum with normalized intensities between 290-400 nm of compounds 4a-c at the
respective excitation wavelengths to observe the emission each HOMO/LUMO gap.

The emission spectrum reveals emission wavelengths of increasing emission
energy from 4b to 4a to 4c. The spectral data is portrayed in Table 1 with absorbance and
emission wavelengths outlined for compounds 4a-c. It is noteworthy that the original
UV-Vis spectrum for compound 4b was significantly less intense at 1.24 μM
concentration than 4a and 4c. Because of this, Figure 28 and Figure 29 depict 4b as 12.4
μM because it provides a better intensity comparison, but the calculation of
HOMO/LUMO wavelength gap within UV-Vis utilizes the 10-fold diluted scan. These
were calculated by tabulating the average baseline absorbance from 410-800 nm, then
taking the minimum percentage increase from this baseline <410 nm.
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Table 1. UV-Vis and fluorescence spectroscopy absorbances, emissions, and concentrations associated to spectral
scans with compounds 4a-c.

Compound
2-F-BTZ-CBZ
(4a)
3-F-BTZ-CBZ
(4b)
4-F-BTZ-CBZ
(4c)

UV-Vis
Concentration
(μM)

UV-Vis λ
(nm)

0.077 μM

402 nm

0.008 μM

345 nm, 437 nm

0.124 μM

401 nm

0.014 μM

350 nm, 446 nm

0.123 μM

402 nm

0.012 μM

345 nm, 429 nm

Fluorescence
Fluorescence Ex/Em λ
Concentration (μM)
(nm)

This indicates that compound 4-BTZ-CBZ (4c) has the shortest blue emission
wavelength with that is associated with the most energy. This is because compound 4c
has the largest dipole between the donor and acceptor. This promotes the highest energy
between the HOMO/LUMO at 429 nm compared to 437 nm for 4a and 446 nm for 4b.
Reflecting the 19F NMR data from Figure 27, the position of the fluorine appears to
dictate the capability of energy emission between the carbazole donor and benzothiazole
acceptor.
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IV.

Conclusion

There were several conditions and purification methods that were employed for the
synthesis of 4a-c including its precursors. This was highly dependent on product to
impurity ratios before workup procedures, which was greatly monitored through GC/MS
analysis. The represented experimental procedures are the optimized synthetic routes and
purification processes of benzothiazole based chromophores because they maximized in
characteristics of highest yield and purity. 1H, 13C, and 19F NMR spectroscopy was
heavily relied on for final product purity analysis. Tabulations of chemical shift,
integration propagations, and J value coupling constants verified the structural
assignments and confirm purification methods to be successful as well as reflecting to
GC/MS and melting point analysis.
From here, pure 4a-c could be analyzed further through UV-Vis spectroscopy and
allowed for a rough gauge of calculating a HOMO/LUMO gap absorption. These
calculations tended to be lower than fluorescence emission data. UV-Vis for compounds
4a-c found between 402, 401, 402 nm but fluorescence demonstrated 437, 446, 429 nm,
respectively. Para substitution of fluorine will induce highest energy association between
donor and acceptor group compared to meta and ortho isomers. Compound 4c
demonstrated through 19F NMR that the largest dipole exists between the donor and
acceptor moieties, which indicates that this particular position will inquire the most
electron withdrawing properties. From this, sequential synthesis implementing NAS
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chemistry will promote fluorine to be a good leaving group to substitute onto a free
amine.
Future Work
The next anticipated work will consist of properly attaching the chromophore directly
to a free amine on HPEI. The proposed Scheme 6 is a hydroxylation of the fluorine atom
through a mixture of KOH base and water. Fluorine, in this case, acts as a good leaving
group, and is displaced by a hydroxy anion. Following this step is a condensation reaction
with amine and the hydroxy group.

Scheme 6. Synthesis with 2-(3-fluorophenyl)-6-(carbazol-9-yl)-1,3-benzothiazole (4b) with 50:50
KOH/H2O mixture in DMSO at 150 °C to form 2-(hydroxyphenyl)-6-(carbazol-9-yl)-1,3-benzothiazole
derivatives (5b).

Considering the promising results from affirming the purity and structure of
newly developed chromophores, synthesis of HPEI-BTZ-CBz (8c) can be pursued.
The most optimal proposed route will be the utilizing compound 4c as a chromophore
tag to HPEI-IBAm0.61 (7) as a baseline vector. Compound 4c is theorized to have the
highest reactivity at the fluorine site because of both electron withdrawing and
inductive properties in reference to the benzothiazole ring. Both the ortho and para
sites are activated from this benzothiazole withdrawer group, and the para position is
the least sterically hindered site as opposed to the ortho. As seen through previous
studies, vectors with the highest transfection efficiency with lowest cytotoxicity rates
are presumed to be the butylated or pegylated functionalized amines. This is the case
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because it masks the cationic backbone of HPEI along with enhancing uptake with a
hydrophobic membrane of cells. Scheme 7 represents the projected reaction
conditions that will produce product 8c, which will only require chromophore
functionalization of ~2% as previously studied. An initial attempt of this synthesis of
compound 8c was shown to be inconclusive based off NMR results.

Scheme 7. Synthesis of HPEI-IBAm0.61(7) with 4-F-BTZ-CBz (4c) to form HPEI-IBAm0.61-BTZ-CBz (8c).

In order to enhance chromophore synthesis in yield to make a more cost-effective
and time-efficient route, new schematics have been reviewed. One of which has been a
“pre-functionalization” route of a simplistic small molecule synthesis of high yield. The
preliminary reaction initiates at a benzoic acid derivative undergoing nucleophilic
substituting with 4-bromo-aniline, which produces an aniline derivative. From here,
sequential steps consist of sulfonating the newly formed carbonyl with Lawesson’s
reagent, inducing a catalytic cyclic ring closure, and then utilizing the same conditions
with the carbazole NAS substitution as used previously. The proposed schematic with
conditions is demonstrated in Scheme 8 below. This effectively removes the obstacle of
polarity similarities, thus limiting purification complications, with iodinated compounds.
The syntheses are thought to produce a much higher yield and contain minimized
purification steps.
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Scheme 8. Proposed alternative synthetic route for benzothiazole-based chromophores
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VI.

Appendix: Additional Synthetic Details

2.2.2 Synthesis of 2-(3-fluorophenyl)-6-iodo-benzothiazole, 3-F-BTZ-I (3b)
In an oven-dried 10 mL RBF, equipped with a nitrogen inlet, and stir bar, were
placed 3-F-BTZ (0.504 g, 2.21 mmol) and 1.5 mL of H2SO4. A solution of Niodosuccinimide (0.501 g, 2.23 mmol) in 2.0 mL of H2SO4 was added dropwise to the 3F-BTZ stirring solution over 24 hours. The resulting mixture was stirred at room
temperature for 24 hours at which point GC/MS analysis of an aliquot precipitated in
water indicated ~75% conversion. An additional 0.2 equivalents of NIS solution (0.0976
g, 0.434 mmol) were added, and the reaction was stirred for another 24 h. The reaction
mixture was then added dropwise to 400 mL of stirred water, and the resulting precipitate
was isolated via vacuum filtration. The brown dried solid was dissolved in
dichloromethane (~6 mL) and transferred to a 125 mL separatory funnel. The organic
layer was washed with an equal volume of 5% sodium bicarbonate solution and then an
equal volume of DI water. The organic layer was dried over MgSO4, filtered, and the
dichloromethane was removed in vacuo using a rotary evaporator. The remaining solids
were dissolved in chloroform (~5 mL), placed in a 125 mL separatory funnel, and washed
with an equal volume of 10% sodium bisulfite, three times with DI water, and once with
brine solution. The organic layer was dried over MgSO4, filtered, and the chloroform was
removed using a rotary evaporator. The remaining solids were recrystallized from EtOH
with isolated light brown solid ~100%. Yield: 53 mg (~ 7%). GC/MS (m/z): 355.0 amu;
m.p. 144-146 °C.
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2.2.3 Synthesis of 2-(3-fluorophenyl)-6-iodo-benzothiazole, 3-F-BTZ-I (3b)
In an oven-dried 10 mL RBF, equipped with a nitrogen inlet, and stir bar, were
placed 3-fluorophenyl-benzothiazole (0.551 g, 2.41 mmol) and 1.5 mL of H2SO4. A
solution of N-iodosuccinimide (0.657 g, 2.92 mmol) in 2.5 mL of H2SO4 was added
dropwise to the 2-F-BTZ stirring solution over 24 hours. The resulting mixture was
stirred at room temperature for 24 hours at which point GC/MS analysis of an aliquot
precipitated in water indicated ~80% conversion. An additional 0.2 equivalents of NIS
solution (0.109 g, 0.484 mmol) were added, and the reaction was stirred for another 24 h.
After 24 hours, GC/MS analysis of an aliquot precipitated in water indicated ~88%
conversion to monosubstituted product and 5% disubstituted product. The reaction
mixture was then added dropwise to 800 mL of stirred water, and the resulting precipitate
was isolated via vacuum filtration. The brown dried solid was dissolved in
dichloromethane (~15 mL) and transferred to a 125 mL separatory funnel. The organic
layer was washed with an equal volume of 5% NaHCO3 solution forming an emulsion.
Salt and more NaHCO3 solution were added in attempt to break up the emulsion layer.
The organic and residual emulsion layers were then washed with an equal volume of DI
water. The organic layer was dried over MgSO4, filtered, and the dichloromethane was
removed in vacuo using a rotary evaporator. The remaining solids were triturated to
diminish disubstituted material present, and the filtrate was recrystallized from
EtOH/H2O with isolated light brown solid ~97%. Yield: 160 mg (19%). GC/MS (m/z):
355.0 amu.
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2.3.2 Synthesis of 2-(3-fluorophenyl)-6-(carbazol-9-yl)-benzothiazole, 3-F-BTZCBz (4b)
In an oven-dried 10 mL RBF, equipped with a nitrogen inlet, and stir bar, were
placed 3-F-BTZ-I (0.098 g, 2.8 mmol), CuI (0.0062 g, 0.033 mmol), N,Ndimethylglycine (0.0055 g, 0.053 mmol), K2CO3 (0.1255 g, 0.9081 mmol), carbazole
(0.1425 g, 0.8525 mmol) and ~4 mL of DMSO. The resulting mixture was stirred at 90
°

C for 24 hours, at which point GC/MS analysis of an aliquot of the mixture indicated

~86% conversion. An additional 0.2 equivalents of CuI (0.0013 g, 0.0068 mmol), N,Ndimethylglycine (0.0014 g, 0.014 mmol), and K2CO3 (0.0251 g, 0.182 mmol) were
added, and the reaction was continued for another 24 h. After 24 hours; GC/MS analysis
of an aliquot of the mixture indicated ~92% conversion. The reaction mixture was then
added dropwise to 150 mL of stirred water, and the resulting precipitate was isolated via
vacuum filtration. The brown dried solid was dissolved in chloroform (~30 mL) and
transferred to a 125 mL separatory funnel. The organic layer was washed with 2x60 mL
DI water. The organic layer was dried over MgSO4, filtered, and the chloroform was
removed in vacuo using a rotary evaporator. The remaining solids were recrystallized
from EtOH/H2O and triturated in ethanol with isolated light brown solid ~100%. Yield:
27 mg (24%). GC/MS (m/z): 394.1 amu.
2.3.3 Synthesis of 2-(3-fluorophenyl)-6-(carbazol-9-yl)-benzothiazole, 3-F-BTZCBz (4b)
In an oven-dried 10 mL RBF, equipped with a nitrogen inlet, and stir bar, were
placed 3-F-BTZ-I (0.1191 g, 0.3353 mmol), CuI (0.0061 g, 0.032 mmol), N,Ndimethylglycine (0.0094 g, 0.091 mmol), K2CO3 (0.1255 g, 0.9081 mmol), and ~3 mL of
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DMSO. Following this, carbazole (0.1684 g, 1.007 mmol) was added to the stirring
solution and heated to 90 °C over 24 hours. After 24 hours, GC/MS analysis of an aliquot
of the mixture indicated ~72% conversion. An additional 0.28 equivalents of CuI (0.0016
g, 0.0084 mmol), N,N-dimethylglycine (0.0018 g, 0.017 mmol), and K2CO3 (0.1636 g,
1.184 mmol) were added, and the reaction was stirred and heated to 90 °C for another 24
h. After 24 hours, GC/MS analysis of an aliquot of the mixture indicated ~85%
conversion. The reaction mixture was then added dropwise to 150 mL of stirred water
resulting in a milky white mixture. Extraction with chloroform was attempted followed
by drying over MgSO4 and filtering. The chloroform extraction solution was lost in the
rotary evaporator bath.
2.3.4 Synthesis of 2-(3-fluorophenyl)-6-(carbazol-9-yl)-benzothiazole, 3-F-BTZCBz (4b)
In an oven-dried 10 mL RBF, equipped with a nitrogen inlet, and stir bar, were
placed 3-BTZ-I (0.0646 g, 0.182 mmol), CuI (0.0038 g, 0.020 mmol), N,Ndimethylglycine (0.0049 g, 0.048 mmol), K2CO3 (0.0750 g, 0.543 mmol), and ~3 mL of
DMSO. Following this, carbazole (0.0918 g, 0.549 mmol) was added to the stirring
solution and heated to 90 °C over 24 hours. After 24 hours, GC/MS analysis of an aliquot
of the mixture indicated ~90% conversion. The reaction mixture was then added
dropwise to 200 mL of stirred water with salt, and the resulting precipitate was isolated
via vacuum filtration. An extraction with EtOAc from the water mixture was performed
and combined with the precipitate. The organic layer was dried over MgSO4, filtered, and
the EtOAc was removed in vacuo using a rotary evaporator. The remaining solids were
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recrystallized from ethanol/H2O with isolated light brown solid ~100% purity. Yield: ~20
mg (28%). GC/MS (m/z): 394.2 amu; m.p. 150-152 °C.
4.2.2 Synthesis of 2-(2-fluorophenyl)-6-iodo-benzothiazole, 2-F-BTZ-I (3a)
In an oven-dried 10 mL RBF, equipped with a nitrogen inlet, and stir bar, were
placed 2-F-BTZ (0.5587 g, 2.448 mmol) and 2 mL of H2SO4. A solution of Niodosuccinimide (0.7723 g, 3.437 mmol) in 4 mL of H2SO4 was added dropwise to the 2F-BTZ stirring solution over 24 hours. The resulting mixture was stirred at room
temperature for 24 hours at which point GC/MS analysis of an aliquot precipitated in
water indicated ~90% conversion. The reaction mixture was then added dropwise to 800
mL of stirred water, and the resulting precipitate was isolated via vacuum filtration. The
brown dried solid was dissolved in chloroform (~15 mL) and transferred to a 125 mL
separatory funnel. The organic layer was washed with an equal volume of 5% NaHCO3
solution forming an emulsion. Salt and more NaHCO3 solution were added in attempt to
break up the emulsion layer. The organic and residual emulsion layers were then washed
with an equal volume of DI water. The organic layer was dried over MgSO4, filtered, and
the chloroform was removed in vacuo using a rotary evaporator. The crude solid was
recrystallized from EtOH/H2O with isolated light brown solid ~95% purity. Yield: 96.5
mg (11%). GC/MS (m/z): 355.0 amu.
4.2.3 Synthesis of 2-(2-fluorophenyl)-6-iodo-benzothiazole, 2-F-BTZ-I (3a)
In an oven-dried 15 mL RBF, equipped with a nitrogen inlet, and stir bar, were
placed 2-F-BTZ (0.4513 g, 1.977 mmol) and 2 mL of H2SO4. A solution of Niodosuccinimide (0.6266 g, 2.785 mmol) in 4 mL of H2SO4 was added dropwise to the 2F-BTZ stirring solution over 24 hours. The resulting mixture was stirred at room
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temperature for 24 hours at which point GC/MS analysis of an aliquot precipitated in
water indicated ~75% monosubstituted conversion and 25% disubstituted conversion.
The reaction mixture was then added dropwise to 700 mL of stirred water, and the
resulting precipitate was isolated via vacuum filtration. The light brown solid was
collected and an attempt to purify through flash column chromatography (EtOAc/hexanes
1:10) and dried in vacuo with isolation of a white, crystalline solid (324 mg). The
following are the fractional distributions of product purification:
Fractions 1-9 (Mono: 59.2%, Di: 37.2%, Tri: 3.6%)
Fractions 10-12 (Mono: 82.3%, Di: 17.7%)
Fractions 13-39 (Mono: 80.1%, Di: 19.9%)
Fractions flush (Mono: 8.1%, Di: 91.9%)
Column fractions 10-39 were subjected through a series of triturations and
recrystallizations that gave the highest purity from recrystallizing in EtOH/H2O with
isolated white solid powder ~89% purity. Yield: 50 mg (~7%). GC/MS (m/z): 355.0 amu.
4.2.4 Synthesis of 2-(2-fluorophenyl)-6-iodo-benzothiazole, 2-F-BTZ-I (3a)
In an oven-dried 15 mL RBF, equipped with a nitrogen inlet, and stir bar, were
placed 2-F-BTZ (0.2701 g, 1.183 mmol) and 2 mL of H2SO4. A solution of Niodosuccinimide (0.2999 g, 1.224 mmol) in 4 mL of H2SO4 was added dropwise to the 2F-BTZ stirring solution over 24 hours. The resulting mixture was stirred at room
temperature for 46 hours at which point GC/MS analysis of an aliquot precipitated in
water indicated ~84% monosubstituted conversion and 8% disubstituted conversion with
8% BTZ starting material. An additional 0.1 equivalents of NIS solution (0.0219 g,
0.0973 mmol) were added, and the reaction was stirred for another 24 h. After 24 hours,

89

GC/MS analysis of an aliquot precipitated in water indicated ~84% conversion to
monosubstituted product and 10% disubstituted product with 7% BTZ starting material.
The reaction mixture was then added dropwise to 700 mL of stirred water, and the
resulting precipitate was isolated via vacuum filtration. The light brown solid was
collected and an attempt to purify through flash column chromatography (EtOAc/hexanes
1:10) and dried in vacuo with isolation of a white, crystalline solid (324 mg). The
following are the fractional distributions of product purification:
Pre-fractions (Mono: 67.5%, Di: 34.5%)
Fractions 1-9 (BTZ: 4.4%, Mono: 82.1%, Di: 13.5%)
Fractions 10-18 (BTZ: 3.4%, Mono: 87.3%, Di: 9.3%)
Column fractions 1-9 and 10-18 were triturated separately in EtOH/H2O with
isolated white solid powder ~95% purity. Yield: 100 mg (~24%). GC/MS (m/z): 355.0
amu.
4.3.2 Synthesis of 2-(2-fluorophenyl)-6-(carbazol-9-yl)-benzothiazole, 2-F-BTZCBz (4a)
In an oven-dried 10 mL RBF, equipped with a nitrogen inlet, and stir bar, were
placed 2-F-BTZ-I (0.2029 g, 0.5713 mmol), CuI (0.0112 g, 0.0588 mmol), N,Ndimethylglycine (0.0127 g, 0.123 mmol), K2CO3 (0.2368 g, 1.713 mmol), and ~5 mL of
DMSO. Following this, carbazole (0.2813 g, 1.683 mmol) was added to the stirring
solution and heated to 90 °C over 24 hours. After 24 hours, GC/MS analysis of an aliquot
of the mixture indicated ~95% conversion. The reaction mixture was then added
dropwise to 200 mL of stirred water with salt and extracted with 2x150 mL EtOAc from
the water mixture. These washes were combined, dried over MgSO4, filtered, and the
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EtOAc was removed in vacuo using a rotary evaporator. The crude purity through
GC/MS analysis revealed 63:36 carbazole starting material to product. At this point, the
solids were redissolved in chloroform, washed with 2x50 mL water, dried over MgSO4,
filtered, and the chloroform was removed in vacuo using a rotary evaporator. The purity
through GC/MS analysis revealed 75:25 starting material to product at this point. The
remaining solids were recrystallized from EtOH/H2O and triturated in hexanes with
isolated light brown solid ~100% purity. Yield: 45 mg (20%). GC/MS (m/z): 394.1 amu.
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Figure 31. 13C NMR (100 MHz, CDCl3) spectrum within the aromatic region of 4-F-BTZ (2c).
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Figure 32. 13C NMR (100 MHz, CDCl3) spectrum within the aromatic region of 4-F-BTZ-I (3c).
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Figure 33. 13C NMR (100 MHz, CDCl3) spectrum within the aromatic region of 4-F-BTZ-CBz (4c).
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Figure 34. 1H NMR (400 MHz, CDCl3) stacked spectra within the aromatic region of 4-F-BTZ-CBz (4c, blue), 4-FBTZ-I (3c, red), and 4-F-BTZ (2c, green) (*CHCl3).

95

Figure 35. 19F NMR (376.5 MHz, CDCl3) stacked spectra of 4-F-BTZ-CBz (4c, blue), 4-F-BTZ-I (3c, red), and 4-FBTZ (2c, green).
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Figure 36. 13C NMR (100 MHz, CDCl3) spectrum within the aromatic region of 3-F-BTZ (2b).

97

c

c
d

a

e

e

b a

d

f g
i

l

h i

m
l

j

k

j

k

g
b
m

f
h
d
k
j
l

e

i
c
a

Figure 37. 13C DEPT90 NMR (100 MHz, CDCl3) of 3-F-BTZ 13C scan (blue) and 3-F-BTZ DEPT90 scan (red)
representing only 1°, 2°, and 3° carbons (3a).
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Figure 38. 13C NMR (75 MHz, CDCl3) spectrum within the aromatic region of 3-F-BTZ-I (3b).
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Figure 39. 13C NMR (100 MHz, CDCl3) spectrum within the aromatic region of 3-F-BTZ-CBz (4b).
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Figure 40. 1H NMR (400 MHz, CDCl3) stacked spectra within the aromatic region of 3-F-BTZ-CBz (4b, blue), 3-FBTZ-I (3b, red), and 3-F-BTZ (2b, green) (*CHCl3).
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Figure 41. 19F NMR (376.5 MHz, CDCl3) stacked spectra of 3-F-BTZ-CBz (4b, blue), 3-F-BTZ-I (3b, red), and 3-FBTZ (2b, green).
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Figure 42. 13C NMR (100 MHz, CDCl3) spectrum within the aromatic region of 2-F-BTZ (2a).
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Figure 43. 13C NMR (100 MHz, CDCl3) spectrum within the aromatic region of 2-F-BTZ-I (2c).
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Figure 44. 13C NMR (100 MHz, CDCl3) spectrum within the aromatic region of 2-F-BTZ-CBz (4a).

105

b

b

a

c

a

c

a
b

d

d

c d

e

h

e

j

h

e

h

i
g

g
g

f

k

i

l

j
l
k
c
c

c

h
e

l
e

e

h

h
g

g
g

b
b
b

f

i+ j

d

d

d+k

a
a

* a

*

*

18

Figure 45. 1H NMR (400 MHz, CDCl3) stacked spectra within the aromatic region of 2-F-BTZ-CBz (4a, blue), 2-FBTZ-I (3a, red), and 2-F-BTZ (2a, green) (*CHCl3).
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Figure 46. 19F NMR (376.5 MHz, CDCl3) stacked spectra of 2-F-BTZ-CBz (4a, blue), 2-F-BTZ-I (3a, red), and 2-FBTZ (2a, green).
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Figure 47. 1H NMR (400 MHz, CDCl3) stacked spectra within the aromatic region of 4-F-BTZ-CBz (4c, blue), 3-FBTZ-CBz (4b, red), and 2-F-BTZ-CBz (4a, green).

108

Figure 48. 1H NMR (400 MHz, CDCl3) stacked spectra of HPEI-IBAm0.61 starting material (blue) and attempted
synthesis of HPEI-IBAm0.61-BTZ-CBz (8c, red)
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Figure 49. Snapshot depicted is the setup for HPEI-IBAm0.60 dialysis in tubing. Clips to hold tubing are attached to
metal clamps onto dialysis bucket to dry out the polymer further.

Diagram 1. The depiction demonstrates the following instruments required to complete the process of speed-vacuum
evaporation: A1-Speed Vacuum (SC110), A2-Refrigerated Fridge Trap (RVT4104), A3-Digital Vacuum Gauge
(DVG50), A4-Savant Filter (VPOF100), and A5-Vacuum Pump (VP100).
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A5

Table 2. Compiled reaction conditions with workup conditions, GC/MS characterization, yield, and final product
description.36-39
Aimed synthesized material
3-F-BTZ
3-F-BTZ-I

GC/MS Pre-work
Demonstrated conversion
Mono: 90%; BTZ: 10%
Mono: 86%; Di: 13%
Mono: 88%; Di: 3%
92% BTZ-CBZ conv
85% BTZ-CBZ conv
94% BTZ-CBZ conv
91% BTZ-CBZ conv
BTZ-CBZ: 69%; unknown
Demonstrated conversion
Mono: 90%; Di: 7%
Mono: 82%; Di: 16%
Mono: 75%; Di: 25%
Mono: 83%; Di: 10%
95% BTZ-CBZ conv
95% BTZ-CBZ conv
Demonstrated conversion
Mono: 99%; Di: 1%
99% BTZ-CBZ conv

Workup conditions
Garrett R. workup
Prec; DCM; 1xbicarb, H2O; re EtOH (re 1:1:8 CHCl3:EtOH:tol fail)
Prec; DCM; 1xbicarb, H2O; re EtOH/H2O; trit MeCN (hexanes, tol fail)
Prec; DCM; 1xbicarb, water
Prec; CHCl3; 2xH2O; 3xtrit EtOH, re EtOH/H2O
Prec; Ex CHCl3; Lost in water bath
Prec (salt); CHCl3; 1xH2O, brine; re EtOH/H2O (MeCN trit fail)
Prec (bicarb, brine); ex EtOAc; 2xH2O wash; re EtOH/H2O
No indication of product conversion
Prec; EtOAc, filtered; 1xbicarb, brine, water; re EtOH
Prec; CHCl3; 1xbicarb, water; add salt H2O layer &CHCl3; re EtOH/H2O
Prec; column 25% DCM/hex (fract 1-58) 10% EtOAc/hex (fract 59-end)
Prec; column 10% EtOAc/hex (fract 10-39), re EtOH/H2O (EtOH trit fail)
Prec; column 10% EtOAc/hex (fract 1-18), trit EtOH/H2O
Prec; ex. Hexanes. EtOAc; 2xtrit hex, EtOH—fil; (re EtOH/H2O fail)
Prec; ex. Hexanes. EtOAc; trit hex—fil; re EtOH/H2O
Prec; EtOAc; 1xbicarb, H2O, brine; no re
Prec; tol; 1xbicarb, H2O, brine; re EtOH/H2O; bisulfite
Prec; CHCl3; 2xH2O wash; re EtOH/H2O

GC/MS Mono Final
"100%"
99.8% (small scale), ~100% large
EtOH/H2O: 81%; Trit MeCN 90%
97%
~100%
—
~100%
~100%
BTZ-CBZ: 69%; unknown
"100%"
95%
93.5% (21-58)
89%
95%
hex fil:81%, EtOH fil: ~100%
hex fil:81%, EtOH/H2O~100%
"100%"
98.76%
~100%

g, yield (%)
2.7316 g, 56%
0.0527g, 7%
0.2804 g, 36%
0.1604 g, 19%
0.0270 g, 24%
Lost in water bath
0.0564 g, 38%
0.0200 g, 28%
—
0.7464 g, 38%
0.0965 g, 11%
Dried: 0.4342 g, 56%
0.050 g, 7%
0.100 g, 24%
0.0450 g, 20%
Dried: 0.0255 g, 15%
Dried: 0.6010 g, 51%
Dried: 0.3063 g, 39%
Undried: 0.099 g, 44%

Color
blue chunky solid
light brown
light brown
light brown
light brown
—
light brown
light brown
—
white crystalline
light brown
white crystalline
off-white
off-white
light brown
light brown
light purple-blue
light pink
light brown

NMR
Yes
Yes
No
No
Yes
No
Yes
No
No
Yes
No
Yes
No
No
No
Yes
Yes
Yes
Yes

MP (oC)

86-89
144-146
No
No
No
No
143-146
150-152
No
70-72
No
133-137
No
No
No
155-160
88-89
165-167
167-169

89-90

Lit MP ( oC)

67-68

97-99

111

3-F-BTZ-CBZ
3-OH-BTZ-CBZ
2-F-BTZ
2-F-BTZ-I

2-F-BTZ-CBZ
4-F-BTZ
4-F-BTZ-I
4-F-BTZ-CBZ

.

